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ABSTRACT OF DISSERTATION 
 
 
 
 
THE ROLE OF INTESTINAL EPITHELIAL CELLS AND THE REGULATION OF 
THE POLYMERIC IMMUNOGLOBULIN RECEPTOR IN HOMEOSTASIS AND 
INFLAMMATION 
 
The mammalian intestine harbors an estimated 100 trillion microorganisms, 
which normally maintain a mutually beneficial relationship with the host. The intestinal 
epithelium consists of a single layer of intestinal epithelial cells (IECs) that provides a 
physical barrier as well as innate immune defense, preventing this vast community of 
microbes from entering host tissues. Secretory immunoglobulin A (SIgA) acts as the first 
line of antigen-specific immunity at the interface between the gut microbiota and the 
intestinal epithelium.  Polymeric IgA secreted by plasma cells in the intestinal lamina 
propria is transported across IECs by the polymeric immunoglobulin receptor (pIgR). 
Defects in epithelial barrier and immune functions can lead to infections with 
opportunistic and pathogenic microbes and contribute to the etiology of inflammatory 
bowel disease (IBD).  Here we investigate the ability of IEC biomarkers to define the 
mechanism and severity of intestinal inflammation, as well as provide insight into the 
function of IEC in regulating intestinal homeostasis and inflammation.  Importantly, 
down-regulation of pIgR expression was a common feature in human IBD and mouse 
models of experimental colitis. One molecule of pIgR is consumed for every molecule of 
SIgA transported, thus high expression of pIgR is required to maintain sufficient supply 
of SIgA. Accordingly, we investigate the mechanisms by which IECs regulate pIgR 
expression in response to colonic bacteria. Cross-talk between the microbiota and IECs is 
mediated by pattern recognition receptors, including Toll-like receptors (TLR), leading to 
expression of gene products that enhance epithelial barrier function and innate immunity. 
The cytoplasmic adaptor protein MyD88 transduces signals from TLRs that recognize 
bacterial products. We show that pIgR induction by colonic bacteria is dependent on 
TLR4-MyD88 activation of NF-κB signaling.  We examined the role of epithelial-
specific MyD88 signaling in antibacterial immunity and epithelial expression of key gene 
products that participate in innate immunity in the gut by generating mice with an IEC-
targeted deletion of the Myd88 gene (MyD88∆IEC).  MyD88∆IEC mice display 
immunological and antimicrobial defects resulting in increased susceptibility to 
experimental colitis. We conclude that cross-talk between bacteria and IECs via MyD88-
dependent signaling is crucial for maintenance of gut homeostasis.  
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(pIgR), MyD88, IgA, Inflammatory Bowel Disease (IBD) 
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Chapter One: Introduction 
“Good fences make good neighbors.”~ Robert Frost 
This mid 17th –century proverb was used by Robert Frost in his 1914 poem 
“Mending Wall”,  in which Frost questions whether rebuilding a stone wall each spring 
between his and his neighbor’s property is actually necessary to maintain good will 
between neighbors.  While it seems that Frost doubts a physical barrier is required to 
maintain these relationships, in the intestine, this proverb can be taken literally.  The 
intestinal epithelium, composed of a single layer of intestinal epithelial cells (IECs), 
provides a biological “fence” that separates the vast number of bacteria in the intestinal 
lumen from host tissue. In addition to this physical barrier, IECs must also provide 
immunological defenses to maintain a symbiotic relationship between microbiota and 
host. When these fences and active defenses fail, intestinal inflammation can result.  In 
this work, the critical role of IECs in regulating intestinal homeostasis and inflammation 
is investigated. 
 
Structure and Function of the Intestinal Epithelium – “The Good Fence” 
Epithelial surfaces, including the skin, respiratory tract, gastrointestinal tract and 
urinary tract, make up the main interfaces between the host and external environment1. 
The primary function of these epithelial surfaces is to provide a physical and 
immunological barrier to prevent invasion by microorganisms, with which these surfaces 
are in constant contact. The quantity and composition of these microorganisms vary 
based on the anatomical site2. In particular, the gastrointestinal tract (GI) is the largest 
reservoir of commensal microorganisms in the mammalian body.  It is estimated that the 
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mammalian gut is home to 1014 bacteria, with at least 1,000 different bacterial species3. 
Bacterial concentrations within the GI tract increase exponentially as it descends from the 
stomach to the distal colon4. The upper GI tract, including the stomach, duodenum, 
jejunum and proximal small intestine contains minimal bacterial loads of fewer than 104 
per gram of luminal contents5.  The bacterial concentrations increase towards the lower 
small intestine, reaching levels of about 107 and 108 cells per gram, while bacterial loads 
increase to approximately 1011 bacteria per gram of stool in the colon4. A single layer of 
intestinal epithelial cells, known collectively as the intestinal epithelium, provides a 
physical barrier that separates the vast number of bacteria in the intestinal lumen from the 
underlying lamina propria1. The intestinal epithelium consists of four major cell lineages 
that arise from a pluripotent stem cell progenitor. These include absorptive enterocytes, 
which make-up the majority of intestinal epithelial cells (IECs), the mucus-producing 
goblet cells, enteroendocrine cells, which are specialized hormone-producing endocrine 
cells in the gastrointestinal tract, and Paneth cells, which are the main producers of 
antimicrobial peptides3 (Figure 1-1).  IECs are structurally and functionally polarized, 
with an apical surface facing the intestinal lumen and a basolateral surface facing the 
underlying lamina propria6. These epithelial cells constitute a large surface area, 
approximately 100m2 for an average human, which is structurally organized by the crypt-
villus axis.   The turnover rate of IECs, which is approximately 3-5 days, is governed by 
the rate of cell proliferation in the crypt as well as the cell shedding at the villus surface3. 
Intestinal stem cells located in the crypt regions undergo proliferation and differentiation 
into enterocytes, enteroendocrine cells, or goblet cells and migrate upward to the top of 
the villus where cellular apoptosis and epithelial shedding occurs. Intestinal stem cells 
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can also differentiate into Paneth cells that migrate downward to the bottoms of the crypts 
(Figure 1-1). During intestinal epithelial cell differentiation and migration, the formation 
of epithelial tight junctions (TJ) occurs at cell-cell contact sites to ensure a virtually 
impermeable barrier. Accordingly, in a healthy gut, the proper expression and formation 
of TJ proteins are the limiting factor that regulates intestinal permeability5. Therefore this 
well organized structure of the intestinal epithelium creates a secure fence that separates 
the neighboring microbiota from the neighboring lamina propria. 
 
Neighbors to the North – The Intestinal Microbiota 
While the primary function of IECs is to maintain spatial separation between 
bacteria and host tissue, thus preventing bacterial invasion and infection, the majority of 
intestinal bacteria maintain a symbiotic relationship with the host.  The colonic 
microbiota break down complex carbohydrates that cannot be metabolized by the host7; 
bacterial fermentation generates short-chain fatty acids that serve as energy sources for 
colonic ECs7; colonic bacteria produce antimicrobial peptides that promote the 
maintenance of a symbiotic community8; and the presence of commensal bacteria protect 
against pathogen colonization by competing for nutrients and space9. Additionally, 
communication between commensal bacteria and IECs has been shown to control the rate 
of epithelial turnover and differentiation, enhance epithelial barrier function and shapes 
the developing mucosal immune system3,10.  
Interestingly, humans are born germ-free but the GI tract is rapidly colonized after 
birth11. The gut microbiota is highly diverse, with 15,000-36000 identified species and at 
least 1,000 different species present in the microbiota of each individual3. However, it is 
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believed that only 30-40 bacterial species represent greater than 99% of an individual’s 
microbiota12. The four major bacteria phyla found in the colonic mucus include 
Firmicutes (~64%), Bacteriodetes (~23%), Proteobacteria (~8%) and Actinobacteria 
(~5%).  While the microbiota generally lives in a symbiotic relationship with the host, 
these bacteria can contribute to disease.  Accordingly, the presence of bacteria is required 
for the development of disease in at least 20 well characterized mouse models of 
experimental colitis13,14.  While techniques to analyze the composition of the microbiota 
are variable, a general “dysbiosis,” or imbalance in the composition of the microbiota, is 
observed in patients with inflammatory bowel disease (IBD)15. Increases in adherent and 
invasive Escherichia coli along with reduced colonization of members of Firmicutes and 
Bacteriodetes have been found in IBD patients compared to healthy individuals15-17.  
However, whether this dysbiosis is a cause or an effect of intestinal inflammation is still 
under investigation14,18.     
 
Neighbors to the South- Immune Cells of the Lamina Propria 
Beneath the intestinal epithelium and separated from the microbiota, a layer of 
mucosal tissue, known as the lamina propria, is a major mucosal effector site that 
functions to recruit T and B cells emerging inductive sites19. The lamina propria is 
composed of stromal cells (mostly myofibroblasts) and immune cells including B cells, T 
cells, macrophages and dendritic cells (DCs) (Figure 1-2)6.  As mentioned, the intestinal 
epithelial barrier in a healthy gut does not allow penetration of commensal bacteria into 
the lamina propria, thus preventing excessive immune responses. However, limited 
bacteria-immune cell interactions occur in a control manner in specialized lymphoid 
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structures, including Peyer’s patches (PPs) of the small intestine and isolated lymphoid 
follicles located throughout the length of the intestinal tract19. These inductive sites are 
located beneath specialized cells within the epithelium known as microfold (M) cells. M 
cells are capable of transporting luminal contents, including commensal bacteria, to 
resident antigen presenting cells (mostly DCs) within the PP or lymphoid follicle (Figure 
1-2)6. Bacterial-laden DCs can then migrate to PP and mesenteric lymph nodes (MLNs) 
where they can induce B and T cells to undergo clonal expansion and differentiation upon 
activation by antigen. The presence of the microbiota also has a strong influence on the 
development of these secondary lymphoid structures that make-up the mucosal associated 
lymphoid tissue (MALT) and gut-associated lymphoid tissue (GALT)20.  Germ-free mice 
exhibit defective MALT and GALT development, including reduced numbers of PPs and 
smaller PPs, smaller and fewer cellular mesenteric lymph nodes (MLNs) and less cellular 
lamina propria, as compared to conventionally raised mice21-23.  
 
Toll-like Receptor Signaling Provides Communication Between Neighbors 
Cross talk between bacteria and host cells is mediated by pattern recognition 
receptors (PRRs).  Toll-like receptors (TLRs) are a family of PRRs that recognize 
pathogen-associated molecular patterns (PAMPs)6.  While the general term PAMP is 
used for these TLR ligands, the molecular patterns that are actually recognized by these 
TLRs are not just from pathogens, but commensal bacteria, viruses and endogenous 
proteins as well.  There are 13 characterized TLRs, 10 of which are homologous between 
mice and humans (Figure 1-3)6.  The TLRs that are primarily responsible for recognizing 
bacterial products, including TLR1 (bacterial lipoproteins), TLR2 (bacterial lipoproteins, 
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peptidoglycans), TLR4 (lipopolysaccharide (LPS), TLR5 (flagellin) and TLR6 (LTA, 
diacyl lipoproteins), are generally expressed on the cell surface6,24. Alternatively, the 
TLRs that are primarily responsible for the recognition of viral components, including 
TLR3 (dsRNA), TLR7 (ssRNA), TLR8 (ssRNA), and TLR9 (bacterial/viral 
unmethylated CpG DNA), are generally expressed on intracellular endosomal 
membranes6. TLRs are inducible or constitutively expressed, at various levels and 
combinations, in all cell-types throughout the intestine24.  However, given the close 
association between IECs and the microbiota, TLR signaling by IEC provide the first line 
of communication between bacteria and host.  
All TLRs are type 1 transmembrane receptors that contain an N-terminal leucine-
rich repeat domain (LRR), a transmembrane region and a C-terminal cytoplasmic 
domain6,25. The C-terminal domain shares high homology to the type-1 IL-1 receptor and 
is thus termed the Toll/IL-1R (TIR) domain26.  Upon ligation of TLRs with an 
appropriate ligand, signaling cascades are activated, resulting in the innate immune 
effector responses as well as the initiation of adaptive immune responses. Stimulation of  
TLRs  leads to the recruitment of cytoplasmic adaptor proteins25. Five adaptor proteins 
have been identified; myeloid differentiation factor 88 (MyD88), MyD88-adaptor like 
protein (Mal/TIRAP), TIR-containing adaptor protein inducing interferon-β (TRIF), Trif-
related adaptor molecule (TRAM) and sterile α- and armadillo-motif containing protein 
(SARM)25.  MyD88 is utilized by all TLRs, except TLR3.  TRIF is utilized by TLR3 as 
well as TLR4. Accordingly, unlike other TLRs, TLR4 utilizes both MyD88 and TRIF via 
recruitment of the bridging adaptors Mal and TRAM (Figure 1-4). These adaptor 
proteins initiate signaling cascades that ultimately lead to the activation of the nuclear 
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factor –κB (NF-κB)27 signaling pathways and parallel activation of several mitogen-
activated protein kinases (MAPK) including c-Jun N-terminal kinase (JNK), extracellular 
signal-regulated kinase ERK (ERK), and p38 MAPK26.  Activation of these signaling 
pathways leads to the induction of pro-inflammatory chemokines, cytokines and 
antimicrobial peptides6,17. Accordingly, NF-κB and MAPK activation is significantly 
reduced in MyD88-deficient mice28. Along with the activation of NF-κB and MAPK, the 
MyD88-independent, Trif-dependent signaling pathway leads to the phosphorylation and 
translocation of IRF3 to the nucleus where it regulates the expression of type 1 
interferons (IFN)26 (Figure 1-4). TLR signaling has been shown to enhance epithelial 
barrier function by inducing expression of tight junction proteins, mucin production, 
antimicrobial peptides and protection against epithelial apoptosis6. Intestinal epithelial 
cells of germ-free mice have reduced expression of TLRs, as compared to conventionally 
raised mice29, suggesting a role for the microbiota in maintaining innate immune 
function.   
The transcription factor NF-κB is a central regulator of inflammatory and immune 
responses in most organ systems. Inactive NF-κB is localized to the cytosol, complexed 
to the inhibitory protein IκB30. Upon stimulation, including TLR signaling, IκB is 
phosphorylated by IκB Kinase (IKK) and degraded, allowing NF-κB translocation to the 
nucleus and induction of gene transcription30,31.  In the intestine, NF-κB signaling has 
diverse functions that govern both protective and destructive immune responses.  
Whether these effects are beneficial or harmful depend on the cell type involved, the 
level of NF-κB activation as well the specific environmental and pathophysiological 
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conditions. While excessive NF-κB signaling in immune cells has been implicated as a 
major contributor to intestinal inflammation, recent studies have indicated that NF-κB 
signaling in IEC is required to maintain intestinal homeostasis30,32,33. Epithelial deletion 
of NEMO, the common regulatory subunit of the NF-κB IKK complex, causes excessive 
intestinal epithelial apoptosis and epithelial barrier defects leading to the translocation of 
commensal bacteria34.  Accordingly, a balance of NF-κB signaling must be maintained to 
achieve a protective level of “physiological” inflammation.  
 
Mucus Layer Provides a Preliminary Line of Defense 
To support this epithelial barrier, a mucus layer covers the single layer of 
intestinal epithelial cells within the small intestine and colon.  This mucus layer is 
composed of transmembrane molecules known as mucins35. The main mucin protein and 
primary structural component of mucus is mucin-2 (MUC2), a large gel-forming protein 
(>100 MDa) produced by goblet cells. Once released from the apical side of the goblet 
cell, MUC2 molecules dimerize and trimerize to form a large network, which can be 
further cross-linked to form a well organized and stable structure35.  Interestingly, the 
small intestine and colon contain very distinct mucus layer properties. The colon is 
protected by an inner and outer mucus layer36. The thick inner mucus layer is relatively 
sterile and firmly attached to the epithelium.  This inner layer is continuously converted 
to a less dense outer mucus layer that is permeable to commensal bacteria35. In contrast, 
the mucus layer of the small intestine is thin and is relatively permeable to the sparse 
bacterial loads found in this area35. These differences in mucus properties are consistent 
with the difference in bacterial concentrations as well as anatomical functions of these 
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two organs5. For example, a dense, tightly bound mucus layer would be detrimental for 
the small intestine, whose primary function is to chemically digest and absorb nutrients 
from ingested food.  On the other hand, the presence of the compacted inner mucus layer 
in the colon facilitates the effective passage of waste and prevents bacteria association 
with the epithelial surface. Accordingly, mice deficient in Muc2 demonstrate increase 
epithelial permeability and bacteria penetration of the intestinal epithelium37,38. 
 
An Epithelial Immune Barrier Reinforces the Physical Barrier 
In addition to forming an impermeable physical barrier, IECs also actively 
maintain an immunological barrier to prevent bacterial penetration.  IECs secrete a broad 
range of antimicrobial peptides (AMPs), including defensins, cathelicidins and 
calprotectins that exhibit broad-spectrum antibiotic activity against bacteria, fungi, 
viruses and yeast3. These small cationic peptides are secreted into the lumen of the gut in 
response to microbial stimulation1. Once in the mucus layer, the majority of AMPs can 
insert themselves into bacterial membranes, resulting in bacterial cell lysis1. Analyses of 
antimicrobial activity in luminal contents indicate that AMPs are retained in the mucus 
layer and are not found in the lumen39. Accordingly, a diffusion barrier is created that 
concentrates levels of AMPs near the epithelial surface, increasing the effectiveness of 
these proteins in the protection of the epithelium from bacterial adherence and 
penetration40.  All IEC lineages produce and secrete AMPs, although Paneth cells located 
in the epithelial crypts are known to be the main source of AMPs1,35. Several AMPs are 
constitutively expressed, including many defensins, while some subsets of AMPs require 
TLR activation by specific bacterial subsets40. MyD88-deficient mice have undetectable 
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levels of the AMP regenerating islet-derived protein 3γ (RegIIIγ)41 and it has recently 
been shown that RegIIIγ expression was reduced in the small intestine of mice with an 
epithelial deletion of MyD8842.  Furthermore, in the absence of MyD88 or Paneth cell 
development there is an increase in the translocation of commensal and pathogenic 
bacteria43.  Taken together, these results suggest that bacterial-IEC cross-talk mediated by 
MyD88 signaling is crucial for the expression of AMPs that limit the invasion of 
commensal and pathogenic bacteria. However, the role of epithelial MyD88 signaling in 
regulating antimicrobial activity in the colon has not been investigated. 
 
SIgA Provides the First Line of Antigen-Specific Defense 
Secretory antibodies of the IgA class (SIgA) provide the first line of antigen-
specific immune protection in the gut against potential pathogens44. SIgA antibodies in 
mucosal secretions contribute to intestinal homeostasis by limiting access of microbial 
and environmental antigens to the host tissue, maintaining the integrity of the epithelial 
barrier and shaping the composition of the commensal microbiota45,46. IgA is the 
predominant antibody isotype in mucosal tissues and comprises approximately 75% of 
the total antibody production in the mammalian body.  However, IgA antibodies are a 
minor component of serum (systemic) antibodies, which highlights the importance of the 
mucosal immune system in human immunity47. There is a clear association between the 
commensal microbiota and the induction of IgA responses. IgA levels in mucosal 
secretions and the number of IgA-producing plasma cells in the lamina propria are 
increased several orders of magnitude between colonized and germ-free mice of the same 
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strain48. Thus, the significant induction of intestinal IgA in the presence of commensal 
bacteria supports a major role for IgA in protection at these mucosal sites.  
The production of IgA-specific for commensal bacteria can occur via several well 
orchestrated interactions between bacteria and immune cells within the GALT49 (Figure 
1-5). DCs in the PPs and lymphoid follicles capture bacteria internalized by M cells and 
migrate to the interfollicular region of the PPs or MLNs where they present antigen to 
CD4+ T cells. Antigen-activated T cells can induce B cells to differentiate into IgA+ 
plasma cells that home, by means of α4B7, CCR9 and/or CCR10 expression, to the 
lamina propria1,4. T-cell independent IgA responses have also been demonstrated47,50. 
The intestinal lamina propria also contains IgM+ B cells that are thought to be a 
precursor of IgA-producing plasma cells51. Lamina propria DCs can directly present 
antigen to these B cells52, and provided stimulation with additional B-cell stimulating 
factors occurs, can induce B cell differentiation into IgA+ plasma cells within the lamina 
propria50.  Lastly, IECs and DCs can directly initiate the class switch recombination from 
IgM to IgA by releasing B-cell activating factors, such as BAFF and APRIL, in response 
to TLR signaling4,19.  Both BAFF and APRIL are recognized by the BAFF receptor and 
transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) 
receptor on B cells, which utilize the MyD88-dependent activation of NF-κB to initiate 
class switch recombination53. 
IgA secreted by plasma cells in the lamina propria must be transported across the 
epithelial layer in order to protect the epithelial surface from colonization and invasion by 
pathogenic bacteria.  This transport process is mediated  by the polymeric 
immunoglobulin receptor (pIgR)44 (Figure 1-6). pIgR is a mucosal epithelial specific 
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protein that is synthesized as an integral membrane protein and is targeted to the 
basolateral side of the epithelial cell. At the basolateral surface, pIgR can bind dimeric 
IgA secreted by IgA+ plasma cells in the lamina propria. pIgR and bound IgA is then 
endocytosed and transported to the apical side of the epithelial cell.  At the apical side, 
non-specific proteolytic cleavage of pIgR occurs, resulting in the release of the secretory 
component (SC) of pIgR bound to IgA. This complex is known as SIgA.  This transport 
process provides multiple levels of immune protection (Figure 1-7): pIgR has been 
shown to excrete potentially harmful IgA-containing immune complexes from the lamina 
propria into the lumen54. Transcytosis of SIgA has been shown to neutralize viruses and 
microbial products within IECs55.  At the apical surface, release of SIgA and SC, both of 
which have mucus-binding properties that facilitate the trapping of bacteria within the 
mucus layer, enhances epithelial barrier function and limits bacterial adherence and 
translocation44,46,56. In the absence of dimeric IgA, constitutive transcytosis and cleavage 
still occurs, releasing free SC into mucosal secretions46. Free SC has been shown to 
contribute to innate immunity by acting as a non-specific bacterial scavenger and limiting 
inflammatory immune response54. pIgR deficient mice display reduced levels of IgA in 
mucosal secretions and elevated levels of serum IgA57.  Moreover, while IgA deficient 
and pIgR deficient mice are more susceptible to experimental colitis, as compared to 
wild-type mice, pIgR deficient mice develop more severe intestinal inflammation than 
IgA deficient mice, indicating a protective role for SIgA and SC in intestinal 
inflammation58. 
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Regulation of pIgR Expression and Transport of SIgA    
One molecule of pIgR is consumed for every molecule of SIgA transported into 
the lumen, thus the rate of pIgR transcription controls the rate of SIgA transcytosis and 
high expression of pIgR is required to maintain sufficient supply of SIgA and SC44,46. 
Accordingly, steady-state levels of pIgR mRNA in mouse and human IECs are very high. 
pIgR expression has been shown to be regulated in vitro by a range of factors, including 
cytokines, hormones, dietary factors, microbial factors and  viral factors59 (Table 1-1). 
Our lab has shown that expression of pIgR is much higher in the colon than in the ileum 
of both healthy controls and Crohn’s disease (CD) patients, which is likely due to 
enhanced bacterial stimulation of IECs due to greater numbers of commensal bacteria60. 
A direct role for commensal bacteria in inducing pIgR expression in vivo was first 
suggested by demonstrating that germ-free mice monocolonized with the bacterium 
Bacteroides thetaiotamicron resulted in upregulation of pIgR expression61.  Importantly, 
our lab has recently shown that pIgR expression in the colonic mucosa and IgA levels in 
colonic mucus were reduced in MyD88 deficient mice, suggesting that TLR-dependent 
MyD88 signaling may also regulate pIgR expression and IgA transport in vivo62. 
However, in that study it was not determined whether pIgR was regulated directly by 
MyD88 signaling in IECs or indirectly by immune cells in the intestinal lamina propria. 
The work presented here investigates the hypothesis that cross-talk between the 
commensal microbiota and IECs has a central role in the induction of pIgR expression 
and the maintenance of intestinal homeostasis. 
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When Intestinal Epithelial Fences and Defenses Fail- Intestinal Inflammation   
Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and 
Ulcerative colitis (UC), are relapsing, chronic inflammatory diseases of the intestine.  
Although the causes of these diseases remain incompletely understood, IBD is thought to 
result from inappropriate inflammatory responses to normal components of the intestinal 
microbiota in genetically susceptible individuals17.  The adaptive immune system, in 
particular a heightened effector T cell response, has traditionally been the focus of 
investigations into the pathogenesis of IBD63.  However, numerous recent reports have 
demonstrated that a defective innate immune response within the intestinal mucosa is a 
primary contributor 64-68.  In particular, dysfunction of the intestinal epithelium has been 
shown to be a dominant pathway in IBD65. Genetic defects, as well as experimentally-
induced damage, restricted to the epithelium can initiate and promote intestinal 
inflammation in the presence of healthy underlying immunity 34.  Thus given their 
anatomical and functional position, IECs are central to the process of intestinal 
homeostasis.  IEC regulate innate immune responses by controlling bacterial-epithelial 
interactions, as well as regulate adaptive immune responses by controlling epithelial-
lamina propria immune cell cross-talk 65. 
Defective epithelial barriers or dysregulation of these epithelial defenses have 
been shown to lead to a breakdown in intestinal homeostasis and contribute to intestinal 
inflammation69. There are several lines of evidence that support the idea that epithelial 
permeability defects precede the onset of intestinal inflammation5,69.  IBD patients have 
an increase in intestinal paracellular permeability and defects in the regulation of tight 
junctions70. Mice with a constitutively active myosin light chain kinase (MLCK) 
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transgene display increased permeability that is quantitatively and qualitatively similar to 
individuals who are high risk for developing IBD69. Furthermore, this defect in tight 
junction permeability is shown to be sufficient to accelerate the onset and enhance the 
severity of intestinal inflammation71. However, the presence of inflammation has also 
been indicated as a cause of epithelial barrier dysfunction, creating a vicious cycle for the 
aggravation and perpetuation of inflammation3,17. 
Many TLR genetic variants have been associated with human IBD phenotypes 
and susceptibility. Polymorphisms in TLR1, TLR2 and TLR9, resulting in dysfunctional 
epithelial TLR signaling, are associated with increased risk of developing colitis and 
more severe disease72,73. TLR4 variants that result in hyporesponsive LPS-induced TLR 
signaling are associated with more severe CD phenotype 74,75. Mice deficient in 
individual TLRs that recognize bacterial components, including TLR2, TLR4, TLR5, and 
TLR9, as well as MyD88-deficient mice, are more susceptible to DSS colitis6,76-79. 
Deletion of TLR5 alone results in the development of spontaneous colitis80. Furthermore, 
cell type-specific deletions and bone marrow chimera studies have demonstrated that 
epithelial-specific TLR signaling has a protective role against the development of and 
response to intestinal inflammation32,42,43,79,81,82. Notably, epithelial deletion of the 
downstream NF-κB regulatory component NEMO caused severe spontaneous colitis in 
mice34.  Alternatively, there is evidence to suggest that hyperactivation of epithelial TLR 
signaling is associated with disease. Epithelial-specific deletion of the single 
immunoglobulin IL-1 receptor-related molecule (SIGIRR), a negative regulator of 
MyD88-dependent TLR signaling, was shown to increase susceptibility of mice to DSS 
colitis, characterized by constitutive upregulation of pro-inflammatory genes82. In 
16 
 
humans, TLR4 expression is upregulated in primary epithelial cells from CD and UC 
patients with active disease, indicating a state of TLR hyperactivation83. Hyperactivity to 
flagellins, a TLR5 ligand, is observed in sera from patients with CD84,85. Taken together, 
these studies suggest that regulated bacteria-epithelial cell cross-talk is essential for 
maintenance of intestinal homeostasis and prevention of intestinal inflammation.   
The mucus layer has a crucial role in maintaining intestinal homeostasis and a 
breakdown in mucus-related defenses are associated with intestinal inflammation.  Loss 
of goblet cells, resulting in reduced mucin secretion, is a hallmark of IBD1,79. 
Additionally, Muc2-deficient mice, which lack a defined mucus layer, develop severe 
spontaneous colitis37,38. Several studies have suggested that impaired Paneth cell 
development and function and defective IEC secretion of AMPs, in particular α-
defensins, may contribute to CD susceptibility86,87. 
 Our lab has recently revealed that reduced expression of pIgR and dysregulated 
transport of SIgA in the colonic mucosa is commonly observed in CD patients60. 
Additionally, reduced pIgR expression in a subset of CD patients resulted in 
accumulation of IgA deposits in the lamina propria. It is likely that this accumulation of 
IgA in the lamina propria could leak into systemic circulation, resulting in the elevated 
serum concentrations of IgA observed in these patients as well as pIgR-deficient mice60. 
Thus, reduction of pIgR expression during colitis would be predicted to diminish not only 
the antimicrobial function of luminal SIgA, but also the removal of IgA-bound antigens 
from the lamina propria.  These defects would exacerbate local inflammation and 
increase the level of IgA immune complexes,  a potential risk factor for development of 
IgA nephropathy, which has been linked with IBD88.  IgA deficiency, independent of 
17 
 
pIgR expression, is estimated to be 10 times more frequent among patients with intestinal 
diseases than in the general public, and it has been proposed that dysregulation of IgA 
responses to commensal bacteria results in excessive innate pro-inflammatory responses, 
propagating intestinal inflammation19.  Mice deficient in either pIgR or IgA are more 
susceptible to DSS induced colitis58.    
IBD is a significant and growing health problem in the U.S., resulting in four 
million prescriptions, over 200,000 hospitalizations, and approximately 1,000 annual 
deaths. Although progress has been made in the treatment of IBD, many therapeutic 
options include general immunosuppressants and immunomodulatory agents that hardly 
address the diversity of colonic inflammatory phenotypes.  These biological drugs block 
key molecules that are involved in the induction and maintenance of inflammation in 
several signaling pathways, all of which have different contributions in different patients 
89.  Therefore considering the complex nature and the heterogeneous clinical presentation 
of IBD, the need to identify molecular biomarkers that can predict disease behavior is 
critical for personalized therapy and effective clinical management of disease.  
Significant attempts have been made to identify genetic markers of IBD. The information 
that is available include several categories of potential biomarkers, including mucosal 
cytokines and chemokines, adhesion molecules, activation markers, serological markers, 
as well as immune and non immune cell subsets 89-93. Considering the culminating 
evidence that IECs are central to the maintenance of intestinal homeostasis and intestinal 
epithelium dysfunction is associated with IBD pathogenesis, potential IEC biomarkers 
are continually being investigated.  Various studies have shown that IECs inappropriately 
express the class II antigen HLA-DR, as well as the co-stimulatory molecule B7 in 
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actively inflamed mucosa of IBD patients 94,95.  Down-regulation of TLR3 and defensin 
expression and upregulation of TLR4 expression was found in active CD patients83,96,97.  
However, since IBD is clearly a multifactorial disease that results in a range of 
inflammatory phenotypes, multifactorial approaches are being utilized to investigate 
potential IBD biomarkers.  Accordingly, Arsenescu et al. recently identified signature 
mRNA biomarkers in IECs from CD patients that were predictive of clinical 
characteristics and responses to therapy60. These studies analyzing human IBD patients 
are essential for identifying clinical phenotypes and have potential to significantly 
advance diagnostics.  However, due to the limitations associated with working with 
patients, many of these studies do not, or cannot, investigate the underlying mechanisms 
of disease. By understanding the association between the expression of potential 
biomarkers with mechanisms of intestinal inflammation and disease severity, it may be 
possible to evaluate and tailor therapeutic options to address the patient’s specific disease 
course.  
 
Summary and Significance 
Intestinal epithelial cells have the unique and complex job of maintaining physical 
barriers and immunological defenses in order to not only maintain a symbiotic 
relationship with their microbial neighbors, but to prevent these neighbors from causing 
serious harm in the rest of the host’s intestinal and systemic neighborhood (Figure 1-8).  
The overall aim of this work is to investigate the hypothesis that IECs are central 
regulators of intestinal homeostasis and inflammation.  By using a multifactorial 
approach to analyze epithelial gene expression during experimental colitis, patterns of 
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epithelial biomarkers were identified that define underlying mechanisms of inflammation 
and are predictive of disease severity.   Importantly, this study revealed that the 
downregulation of pIgR expression and altered transport of IgA are common features in 
human IBD as well as mouse models of experimental colitis, suggesting that maintaining 
pIgR expression is required for intestinal homeostasis. These results led to the 
investigation into the regulation of pIgR expression by colonic bacteria. By performing a 
series of in vitro experiments utilizing inhibitors and siRNAs targeted against specific 
components of innate immune signaling pathways in IECs, the MyD88-dependent 
activation of NF-κB was identified to be a major regulator of pIgR induction by 
commensal bacteria. To determine whether this regulatory mechanism was functional in 
vivo, a novel mouse model employing an epithelial-specific deletion of the Myd88 gene 
was generated.  Loss of MyD88 signaling in IECs caused significantly reduced 
expression of pIgR, leading to impaired SIgA transport; reduced expression of Muc-2, 
leading to altered mucus production; and reduced expression of AMPs, leading to 
defective mucus-associated antimicrobial activity. Taken together, these results suggest a 
model in which MyD88-dependent bacterial-epithelial cell cross-talk is crucial for 
maintenance of physical and immunological barrier function in the intestine. 
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Figure 1-1 Intestinal epithelial cell lineages and the formation of the crypt-villus 
axis. The intestinal epithelium consists of four major cell lineages that arise from a 
pluripotent stem cell progenitor located in the epithelial crypt region. These include 
absorptive enterocytes, which make-up the majority of intestinal epithelial cells (IECs), 
the mucus-producing goblet cells, enteroendocrine cells, which are specialized hormone-
producing endocrine cells in the gastrointestinal tract, and Paneth cells, which are the 
main producers of antimicrobial peptides. Intestinal stem cells differentiate into 
enterocytes, enteroendocrine cells, or goblet cells and migrate upward to the top of the 
villi where cellular apoptosis and epithelial shedding occurs. Intestinal epithelial stem 
cells can also differentiate into Paneth cells that migrate downward to the bottoms of the 
crypts. (Adapted with permission from Yu et al.WJGP 2012) 
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Figure 1-2 Overview of the structure of the intestinal immune system. The intestinal 
epithelium separates the commensal bacteria in the lumen from the immune cells of the 
lamina propria. A mucus layer containing secreted antimicrobial peptides, SIgA and free 
secretory component (SC) reinforces the physical epithelial barrier. Below the 
epithelium, the lamina propria contains myofibroblasts, B cells, T cells, dendritic cells 
(DCs) and macrophages. Specialized lymphoid structures, including Peyer’s patches, 
allow for sampling of luminal contents.  Antigen-loaded DCs can travel via the 
lymphatics to the mesenteric lymph nodes where they can induce B-cell differentiation 
into IgA-secreting plasma cells. (Adapted with permission from Abreu et al. Nat. Rev. 
Immuno. 2010)  
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Figure 1-3 Toll-like receptors (TLR), PAMPs, and Adaptor proteins. All TLRs that 
predominantly recognize bacterial components utilize the adaptor protein MyD88.  TLR4 
is unique in its ability to signal through MyD88 and Trif. (Adapted with permission from 
Kawai and Akira, Cell Death and Differentiation (2006) 13, 816–825) 
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Figure 1-4. TLR4 signaling pathway. LPS binds to the TLR4 complex on the apical 
surface of IEC, initiating MyD88-dependent (blue) and MyD88-independent (yellow) 
signaling pathways. Both MyD88-dependent and independent signaling pathways can 
lead to the activation of NF-κB and MAPK, resulting in the transcription of inflammatory 
cytokines. (Adapted with permission from Gribar et al. Mol. Med. 2008) 
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Figure 1-5 Production of IgA specific for intestinal bacteria.  1) Dendritic cells (DC) 
in the Peyer’s Patches (PP) and lymphoid follicles capture bacteria internalized by M 
cells and migrate to the interfollicular region of the PP or mesenteric lymph nodes (MLN) 
where they present antigen to CD4+ T cells. Antigen-activated T cells can induce B cells 
to differentiate into IgA+ plasma cells that home to the lamina propria and secrete 
dimeric IgA. 2) Lamina propria DCs can directly present antigen to these B cells, and 
when provided with additional B-cell stimulating factors, can induce B cell 
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differentiation into IgA+ plasma cells within the lamina propria. 3) IECs can deliver IgA-
inducing signals to lamina propria B cells by releasing B-cell activating factors in 
response to TLR signaling. (Adapted with permission from Hooper et al. Nat. Rev. 
Immunol. 10(3):159-69 2010) 
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Figure 1-6 pIgR mediated transcytosis of IgA. The polymeric-Ig receptor (pIgR) is 
synthesized by IECs and targeted to the basolateral side of the epithelial cell. Dimeric 
IgA secreted by plasma cells in the lamina propria is bound by pIgR on the basolateral 
side. This complex is transported via receptor-mediated endocytosis to the apical side of 
the epithelial cell. Here the receptor is cleaved to leave the extracellular secretory 
component (SC) of pIgR bound to IgA. This complex, known as SIgA, binds to mucus 
while the nonfunctional residual component of pIgR is degraded (not shown). (Adapted 
from Janeway et al.Immunobiology: the immune system in health and disease. Third 
Edition. New York: Garland Sciences; 2001) 
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Figure 1-7 Mucosal immune defenses mediated by pIgR and SIgA. The pIgR 
mediated transcytosis of IgA provides several levels of immune protections. 1) Dimeric 
IgA in the lamina propria binds to and excretes antigen back into the lumen via pIgR-
mediated transcytosis across IEC. 2) polymeric IgA bound to pIgR can inhibit 
intracellular virus production and neutralize pro-inflammatory antigens and factors. 3) 
SIgA released in to the intestinal lumen binds and neutralizes bacteria and bacterial 
products, preventing adhesion to and penetration of the epithelium. 4) Free secretory 
component (SC) acts as a non-specific scavenger, neutralizing potential pro-inflammatory 
antigens.  
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Table 1-1 Regulation of pIgR expression in the intestine.   
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Figure 1-8 Colonic epithelial immune defenses. A single layer of intestinal epithelial 
cells, joined together by tight junction (TJ) complexes, creates a physical barrier between 
the intestinal microbiota and the lamina propria. To reinforce this physical barrier, IECs 
also create an immunological barrier. Goblet cells secrete mucin proteins that complex to 
create a well organized mucus layer. IECs secrete antimicrobial peptides that are retained 
in the mucus layer. Additionally, IgA secreted by plasma cells in the lamina propria is 
transported by pIgR across the epithelium. SIgA and free secretory component (SC) are 
released into the mucus layer where they can bind bacteria and bacterial products.    
(Adapted with permission from Hooper et al. Nat. Rev. Immunol. 2010)  
Copyright © Aubrey L. Frantz 
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Chapter Two: Materials and Methods 
 
Animals 
Six-week old female wild-type C57BL/6 and 8-week old female Rag1-/- C57BL/6 
mice were purchased from the Jackson Laboratories (Bar Harbor, ME). Mouse strains 
used in the generation of MyD88∆IEC mice were on the C57BL/6 background and 
purchased from Jackson Laboratories (Bar Harbor, ME). Mice of the B6.129P2-
MyD88tm1Defr/J strain were intercrossed to generate mice homozygous for loxP-flanked 
Myd88 (MyD88Flox).  The B6.SJL-Tg (Vil-cre) 997Gum/J strain, which is transgenic for 
Cre recombinase under control of the intestinal epithelial-specific mouse Vil1 gene, was 
intercrossed with MyD88Flox mice to generate mice with a targeted deletion of the Myd88 
gene in epithelial cells in the small and large bowel (MyD88∆IEC). Experiments were 
conducted with littermates generated by crossing MyD88∆IEC mice hemizygous for the 
Vil1-Cre transgene with MyD88Flox mice. All mice were housed in microisolator cages 
with sterile bedding, food and water in AAALAC-accredited facility. All procedures 
were conducted in accordance with guidelines set forth by the University of Kentucky 
Institutional Animal Care and Use Committee.  
 
DSS Model of Acute Colitis  
Acute colitis was induced by oral administration of dextran sulfate sodium (DSS), 
as described98. DSS (molecular weight 36,000 –50,000; MP Biomedicals, Aurora, OH) 
was dissolved in water at indicated concentration and given ad libitum to mice for 8 days 
in place of normal drinking water. Water intake was measured daily to ensure consistency 
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in DSS intake among mice. A disease activity index (DAI) was calculated daily for each 
mouse during DSS treatment, on a 0-4 scale that assessed weight loss, stool consistency, 
and fecal blood (visible and occult). Weight loss scores were determined as 0 = no weight 
loss, 1 = 1–5% weight loss, 2 = 6–10% weight loss, 3 = 11 -15% weight loss, and 4≥15% 
weight loss. Stool scores were determined as 0 = normal stools, 2 = loose stools, 4 = 
diarrhea. Bleeding scores were determined as 0 = no bleeding, 1 = positive guaiac occult 
blood test (minimal color change to green), 2 = positive guaiac occult blood test 
(maximal color change to blue), 3 = blood visibly present in the stool, no clotting on the 
anus, and 4 = gross bleeding from the anus with clotting present. ColoScreen-ES testing 
kits (Helena Laboratories, Beaumont, TX) were used to detect occult blood. ColoScreen-
ES testing kits (Helena Laboratories, Beaumont, TX) were used to detect occult blood.  
 
T cell Transfer Model of Chronic Colitis 
Chronic colitis was induced by adoptive transfer of naïve T cells from wild-type 
mice into Rag1-/- recipients, which lack B and T lymphocytes, as described99. To purify 
T-effector (Teff) and T-regulatory (Treg) cell populations for adoptive transfer, single 
cell suspensions from spleens of 10 week-old wild-type C57BL/6 mice were prepared in 
phosphate-buffered saline with 4% fetal bovine serum. In two of the three independent 
experiments, CD4+CD45RBhi and CD4+CD45RBlo cell populations were isolated by 
fluorescence-activated cell sorting. Spleen cells were labeled with anti-CD4 antibodies 
(eBiosciences, San Diego CA) and anti-CD45RB (Biolegend, San Diego CA) and sorted 
into CD4+CD45RBhi (as a source of Teff) and CD4+CD45RBlo fractions (as a source of 
natural Treg), defined as the uppermost 30% of cells with the brightest CD45RB staining 
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and the lowest 15% of cells with the dimmest CD45RB expression, respectively (Figure 
3-1A, left panel). The Teff and Treg fractions were subsequently demonstrated to differ 
dramatically in cell surface expression of CD25, a marker for natural Treg (Figure 3-1A, 
right panel). In one of the three independent experiments, CD4+ splenic T cells were 
separated into CD25- (Teff) and CD25+ (Treg) populations by magnetic bead sorting 
using the Regulatory T cells kit (Miltenyi, Auburn CA). Nine-week-old Rag1-/- C57BL/6 
mice received a single intraperitoneal injection of 4 x 105 purified Teff, with or without 1 
x 105 purified Treg. Following adoptive transfer, body weight was monitored every 3 
days and mice were sacrificed at 10 weeks post-transfer. No significant differences were 
observed in clinical parameters, tissue histology or colonic EC gene expression that could 
be attributed to the different methods of purification of Teff and Treg populations 
(immunofluorescence vs. magnetic beads). 
 
Tissue Histology 
Colons were dissected from euthanized mice and the length of the colon from the 
anus to the cecal junction was measured. For T cell transfer colitis, colons were weighed 
and the weight/length ratio was calculated. Colons were cut lengthwise, and half of each 
colon was prepared in a “Swiss roll”100 and fixed in 10% buffered formalin (Fisher 
Scientific, Fair Lawn, NJ). Fixed tissues were embedded in paraffin, sectioned, stained 
with hematoxylin and eosin, and evaluated in a blinded fashion for evidence of 
inflammation and epithelial damage. Tissue damage for DSS colitis was quantified on a 
scale from 0–4 as previously described98, using the following criteria: 0, no change from 
normal tissue; grade 1, mild inflammation present in the mucosa, comprised mainly of 
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mononuclear cells, with little epithelial damage; grade 2, multifocal inflammation greater 
than a grade 1 score, including mononuclear cells and some neutrophils, detachment of 
crypt glands from the muscularis mucosae, mucin depletion from goblet cells, and 
occasional detachment of the epithelium from the mucosa; grade 3, multifocal 
inflammation greater than a grade 2 score, including mononuclear cells and neutrophils 
infiltrating the submucosa, crypt abscesses present with increased mucin depletion, and 
significant epithelial disruption, including some ulceration; grade 4, crypts no longer 
present, severe mucosal inflammation mainly composed of neutrophils, and epithelium 
no longer present or completely detached. An average of 4 fields of view per colon were 
evaluated for each mouse to obtain a composite score. For T cell transfer colitis, a total 
histopathological score was calculated by combining the scores for each of the seven 
following parameters for a maximum score of 17: degree of inflammation in the lamina 
propria (score 0-3), goblet cell loss (score 0-3), abnormal crypts (score 0-3), presence of 
crypt abscesses (score 0-1), mucosal erosion and ulceration (score 0-1), submucosal 
spread to transmural involvement (score 0-3), and number of neutrophils counted at 40x 
magnification (score 0-3). 
 
Colonic Epithelial Cell Isolation 
CEC were isolated as previously described 101. Colons were opened 
longitudinally, cut into 1 mm pieces, and the mucus layer was removed by incubation for 
20 min with agitation at 37°C in a solution of 1mM dithiothreitol (Sigma, St. Louis MO) 
in DMEM:Ham’s F-12 (1:1) tissue culture medium (Lonza, Walkersville MD), 
supplemented with 5% fetal bovine serum and antibiotics (100 U/ml penicillin, 100 
34 
 
µg/ml streptomycin, and 250 ng/ml fungizone) (Invitrogen Life Technologies, Carlsbad 
CA). The supernatants were discarded, and CEC were stripped from the colon pieces by 
incubation for 1 h at 37°C in a solution of 0.5 M EDTA in supplemented tissue culture 
media. The suspension was vortexed vigorously, and the remaining colon fragments were 
allowed to settle at the bottom of the flask. The upper layers were centrifuged at 2000 
rpm for 10 minutes at 4°C to collect ECs. Further purification of the CEC fraction was 
accomplished by resuspension of the cell pellets in a 10 ml solution of 30% w/v Percoll 
(Sigma) and centrifugation at 1300 rpm for 20 min at room temperature. The top layer 
containing floating CEC was removed and transferred into a 15 ml conical tube. The 
volume was brought to 10 ml with supplemented tissue culture medium, and the CEC 
solution was pelleted by centrifugation at 2000 rpm for 10 min at 4°C. CEC viability, 
assessed by trypan blue exclusion, was typically > 90 %. Flow cytometry analysis of 
representative CEC preparations indicated that contamination with CD45+ hematopoietic 
cells was approximately 0.4 % for control mice and 1.3 % for DSS-treated mice (Figure 
3-1B).  
 
Analysis of mRNA Levels by Real-time PCR and Nanostring nCounterTM 
Hybridization 
mRNA levels for individual genes were analyzed by quantitative reverse 
transcriptase-polymerase chain reaction (qRT-PCR) as previously described102. Total 
RNA was purified from isolated CEC using the Qiagen RNeasy Protect mini kit (Qiagen, 
Germantown MD). RNA was reverse-transcribed to generate cDNA templates using the 
TaqMan Gold RT-PCR kit (Applied Biosystems, Foster City, CA). Specific mRNA 
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levels were quantified by quantitative real-time polymerase chain reaction, using the ABI 
Prism 7700 Sequence Detection System (Applied Biosystems) as previously described102. 
The level of β2-microglobulin mRNA, which we found did not vary with experimental 
treatments, was used to normalize mRNA for tested genes according to the following 
formula: (2-(CT test – CT β2-microglobulin)) x 100%. For mRNA analysis using the Nanostring 
nCounterTM hybridization technique, colonic epithelial cells were isolated from freshly 
dissected colons as previously described101.  Abundance of mRNA transcripts was 
analyzed by Nanostring nCounterTM hybridization103, and normalized using an algorithm 
developed by NanoString, Technologies (Seattle, WA).  
 
Immunofluorescence Microscopy 
Sections of formalin-fixed, paraffin-embedded colon tissues were dewaxed and 
rehydrated using standard protocols. Antigen retrieval was performed by incubating 
slides for 20 min at 95°C in 25 ml of 10 mM sodium citrate buffer, pH 6. Endogenous 
peroxidase activity was quenched by incubation for 10 min at room temperature in 25 ml 
of 3% (v/v) H202. Cell-associated pIgR and free secretory component (the cleaved 
extracellular domain of pIgR) were detected by overnight incubation of tissue sections at 
4°C with a polyclonal goat antibody to mouse secretory component (2.5 µg/ml) (R&D 
Systems, Minneapolis, MN). Sections were washed with PBS and incubated for 30 min at 
room temperature with a horseradish peroxidase-conjugated rabbit antibody to goat IgG 
(1µg/ml) (Invitrogen, Camarillo CA). Bound peroxidase was revealed with TSA Plus-
TMR Reagent (Perkin-Elmer, Waltham MA). IgA was detected in the same tissue 
sections by subsequent incubation for 1 hour at room temperature with FITC-conjugated 
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antibody to mouse IgA (1µg/ml) (eBiosciences, San Diego CA). MyD88 was detected 
with a rabbit antibody (Abcam, Cambridge, MA) followed by horseradish peroxidase-
conjugated antibody to rabbit IgG (Invitrogen, Camarillo CA) and TSA Plus-TMR 
Reagent (Perkin-Elmer, Waltham MA). All antibodies were diluted in Blocking Reagent 
(Perkin-Elmer). Sections were mounted with VectaShield (Vector Laboratories, 
Burlingame CA) containing DAPI to visualize nuclei. Stained tissue sections were 
imaged on a Zeiss Axiophot confocal microscope (Carl Zeiss Microscopy LLC, 
Thornwood, NY) with Axiovision image software. 
 
Statistical Analysis 
 Statistical differences in disease parameters mRNA levels, CFU, and disease 
activity were determined by analysis of variance and Fisher’s protected least significant 
difference test. Correlation Z test was used to test for correlations among mRNA levels 
for different biomarkers. Factor analysis was used to reduce the 5 mRNA biomarkers into 
two principal components (PCs), as previously described 104. To assign scores for PC1 
and PC2, the mRNA level for each of the five biomarkers for each mouse was first 
normalized to the mean for that biomarker for all mice within the DSS protocol or the T 
cell transfer protocol. Individual scores for PC1 and PC2 were calculated as the sum of 
the normalized value for each biomarker multiplied by the weight for that biomarker. 
Linear regression analysis was used to compare PC1 or PC2 values with % initial weight, 
colon length or the ratio of colon weight/length, and histological score. For MyD88∆IEC 
and MyD88Flox mice with or without DSS treatment, nineteen genes from a total of 36 
were selected for PCA, based on ranking of P values for the comparison of mRNA 
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transcript levels in MyD88∆IEC and MyD88Flox mice, with and without DSS treatment (n = 
31) (see Tables 5-2, 5-3 and 5-4). Factor analysis by the principal component method3 
detected a significant relationship among the 19 transcripts (x2 = 816.7, p < 0.0001), and 
reduced the data to 4 principal components (PCs) (Figure  5-14). PC1 and PC2 together 
accounted for 68.8% of the overall variance in gene expression, whereas PC3 and PC4 
only contributed minimally (variance proportion < 0.1). Scores for PC1 and PC2 for each 
individual mouse were calculated as the sum of normalized expression levels for each 
gene multiplied by the corresponding coefficient for PC1 and PC2.A one-tailed Student’s 
t test was used to compare TER values for colon tissues. Permutational multivariate 
ANOVA was utilized to compare the fecal microbiota between mouse genotypes, based 
on distance matrices of OTUs. All statistical analyses were performed using StatView 
Software (SAS Institute, Cary, NC). 
 
Cell Culture 
 The HT-29v20 subclone of the human colon adenocarcinoma cell line HT-29 was 
cultured as described. 14 Where indicated, cells were stimulated with human recombinant 
TNF (R & D Systems, Minneapolis, MN) at 10 ng/ml, purified Escherichia coli O26:B6 
LPS (Sigma-Aldrich, St Louis, MO) at 1 µg/ml, pIC (Sigma-Aldrich) at 100 µg/ml. The 
human acute myeloid leukemia cell line THP-1 (Tsuchiya et al., 1980) (a generous gift of 
Dr. Sarah D’Orazio, University of Kentucky) were cultured in DMEM Ham’s F-12 (1:1) 
media supplemented with 5% fetal bovine serum and antibiotics (100 U/ml penicillin100 
ng/ml fungizone) at 37°C and 5% CO2. All cell culture reagents were from Lonza 
Walkersville (Walkersville, MD) or Invitrogen Life Technologies (Carlsbad, CA). THP-1 
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cells were maintained in suspension culture, and were diluted to a density of 1 × 106 
cells/well in 24-well dishes immediately before stimulation. Additionally, HT-29 and 
THP-1 cells were treated with the following TLR ligands at a final concentration of 1 
μg/ml: N-palmitoyl-S-[2,3 bis(palmitoyloxy)- propyl]-Cys-Ser-Lys trihydrochloride 
(Pam3CSK4) (InvivoGen, San Diego, CA), a synthetic tripalmitoylated lipopeptide that 
acts as a ligand for TLR2; or highly purified lipopolysaccharide (LPS) from E. coli 
O26:B6 (Sigma-Aldrich, St. Louis, MO), which acts as ligand for TLR4.  
To knockdown MyD88, HT-29 cells were transfected with SureSilencingTM 
plasmids encoding shRNA specific for human MyD88 or an irrelevant control shRNA 
(SABiosciences, Frederick, MD, cat no. KH00911P), and puromycin-resistant subclones 
were isolated as described105. For  RelA or RelB knockdown experiments, HT-29 cells 
were previously transfected with the pSIREN-RetroQ expression plasmid (BD 
Biosciences, San Jose, CA) encoding RelA, RelB, or an irrelevant control siRNA, 
selected for stable integration of the plasmid by resistance to puromycin, and cloned by 
limiting dilution. The sequence of the RelB siRNA was previously reported. 26 The 
sequence of the RelA siRNA (5’–3’) was 
GATCCGATCAATGGCTACACAGGATTCAAGAGATCCTGTGTAGCCATTGATC
TTTTTTG and the sequence of the control siRNA (5’–3’) was GATCCGCGGGCTG 
ATGCTGCACCAATTCAAGAGATTGGTGCAGCATCAGCCCGTTTTTTG. 
 
Bacterial Culture from Mouse Feces and Tissues 
 Fecal pellets were gently released from dissected colons and homogenized in 
PBS. Luminal washes were collected by flushing colons with 5 ml of PBS, and mucus 
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was collected by gentle scraping. Aliquots of fecal homogenates, luminal washes and 
mucus were cultured for 48 h on LB agar at 37o under anaerobic conditions. For analysis 
of bacterial translocation, MLNs were homogenized in PBS and cultured anaerobically 
for 48 h.  E. coli strain Nissle 1917 (a generous gift of Dr. Ulrich Sonnenborn, 
Ardeypharm GmbH, Herdecke, Germany) was transformed to kanamycin resistance, and  
KanR E. coli were delivered to the mice in the drinking water at a dose of 2.5 x 107 
CFU/ml for 7 days. Feces, luminal washes and colonic mucus were collected as described 
above and cultured anaerobically in 50 µg/ml kanamycin to enumerate CFU.  
 
Measurement of Transmucosal Electrical Resistance (TER) 
 Segments of mouse colon were mounted in 0.3 cm2 aperture Ussing chambers 
(Physiologic Instruments, San Diego, CA), and TER was measured as previously 
described106. Apical and basolateral recording buffers contained 118 mM NaCl, 5 mM 
KCl, 2 mM NaH2PO4, 1.2 mMMgSO4, 1 mM CaCl2, 10mM HEPES, 10mM glucose, 
and 22 mM NaHCO3, pH 7.4, and were bubbled with 95% O2 and 5% CO2 at 37 °C. 
 
Analysis of Mucus-Associated Antimicrobial Activity 
 Colonic mucus was isolated as described above, diluted 1:3 in PBS, and 
concentrated by centrifugation at 2500 rpm for 10 min. 106 CFU of KanR E. coli from a 
mid-log phase culture was added to the mucus, then centrifuged together at 1500 rpm for 
15 min at room temperature. Serial dilutions of bacterial suspensions before and after 
incubation with colonic mucus were cultured anaerobically for 24 h in 50 µg/ml 
kanamycin to enumerate CFU.  
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Bacterial Invasion Assays 
Binding and invasion of HT-29 cells was assessed for E. coli (strain Nissle 1917), 
Klebsiella pneumoniae (strain isolated from MLNs of MyD88∆IEC mice) and Salmonella 
typhimurium (strain SL1344) as described107. Approximately 106 CFU were added to 
monolayers of HT-29 cells at an MOI of 10:1. After 2 h at 37o, cell monolayers were 
washed and lysed with 1% Triton X-100 to enumerate total cell-associated bacteria. 
Parallel co-cultures of bacteria and HT-29 cells were treated with gentamicin (100 μg/ml) 
for 90 min to kill extracellular bacteria, washed and cultured to enumerate intracellular 
bacteria. Membrane-associated bacteria were calculated by subtracting internalized CFU 
from total cell-associated CFU.  
 
Analysis of the Fecal Microbiota 
 Fecal samples were collected from littermate MyD88Flox and  littermate 
MyD88∆IEC mice, and frozen samples of fecal DNA (extracted with the QIAamp DNA 
stool kit, Qiagen, Germantown, MD) were shipped to Second Genome, Inc. (San Bruno, 
CA) for analysis of microbial richness and diversity by the PhyloChipTM microarray 
method108 (www.secondgenome.com).  Bacterial 16S rRNA genes were amplified by 
PCR using the forward primer 5’-AGRGTTTGATCMTGGCTCAG-3’ and reverse 
primer 5’-GGTTACCTTGTTACGACTT-3’, fragmented, biotin labeled, and hybridized 
to the PhyloChip™ Array, version G3. Stained arrays were scanned with a GeneArray® 
scanner (Affymetrix), and analyzed by Affymetrix software (GeneChip® Microarray 
Analysis Suite). All profiles are inter-compared in a pair-wise fashion to determine a 
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UniFrac distance metric, which utilizes the phylogenetic distance between OTUs to 
determine the dissimilarity between communities109. For weighted UniFrac, (WuniFrac), 
both the abundance and dissimilarities among OTUs were considered. The phylogenetic 
tree shown in (Figure 5-9) was generated using the “Interactive Tree of Life” software 
tool110. Based on 14,193 OTUs present in at least one of the mice, a Welch t-test was 
performed across the two genotypes using abundance metrics. Principal Component 
Analysis (PCA) was used to position points on two-dimensional ordination plots based on 
dissimilarity values (Figure 5-10A , left panel). Significant OTUs whose abundance 
characterizes each mouse genotype (Figure 5-10A, right panel) were identified by 
Prediction Analysis for Microarrays, which utilizes a nearest shrunken centroid 
method111. 
 
Analysis of fecal IgA and albumin by ELISA 
 Freshly collected feces were diluted in 50 mM Tris, pH 7.4, 0.14 M NaCl, 1% 
BSA, 0.05% Tween 20, and analyzed by ELISA as previously described11 using mouse 
IgA (Cat. No. E90-103) and mouse albumin (Cat. No. E90-134) ELISA Quantification 
Sets (Bethyl Laboratories, Montgomery TX).  
 
Quantification of Bacteria by qRT-PCR 
Fecal homogenates, luminal washes and mucus were collected as described 
above. Bacterial DNA was extracted by column purification using the QIAamp DNA 
stool mini kit (Qiagen Cat. No. 51504), and the 16S rRNA gene was amplified by real-
time PCR using universal primers as described112. To quantify total numbers of bacteria, 
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CT values from individual samples were compared to regression lines of CT values 
generated using defined quantities of bacterial DNA from representative species from the 
four major phyla of colonic bacteria.  
 
Identification of K. pneumoniae in mesenteric lymph nodes 
Mesenteric lymph nodes (MLNs) were dissected under sterile conditions, 
homogenized in sterile PBS, and cultured for 48 h on LB agar at 37o under anaerobic 
conditions. Approximately 25% of the bacterial colonies had a large, mucoid 
morphology. To identify these bacteria, 12 colonies derived from two different 
MyD88∆IEC mice were harvested and cultured overnight in LB broth at 37o under 
anaerobic conditions. Bacterial DNA was extracted by column purification, and the 16S 
rRNA gene was amplified by real-time PCR using universal primers112. The PCR 
products were ligated into the pGEM-T vector (Promega, Madison, WI), then used to 
transform frozen competent E. coli DH5α (Promega) to ampicillin resistance using 
standard protocols. Two ampicillin-resistant colonies were harvested and cultured in LB 
broth containing 100µg/ml ampicillin. Bacterial DNA was purified using the Qiagen 
miniprep kit (Qiagen, Germantown, MD), and shipped to ACGT, Inc. (Wheeling, IL) for 
sequence analysis. Identical sequences of the unknown 16S rRNA gene (which were 
identical for the 2 colonies analyzed; Figure 5-4A) were compared with the sequences of 
known bacterial genomes by BLAST analysis of the National Center for Biotechnology 
Information database  (http://blast.ncbi.nlm.nih.gov/Blast). The highest alignment scores 
were observed with16S rRNA genes from 5 strains of Klebsiella pneumoniae, and 
slightly lower scores were observed with 16SrRNA genes from other species in the 
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family Enterobacteriaceae, including Escherichia coli (Figure 5-4B). The original 
bacterial colonies cultured from the MLNs of MyD88∆IEC mice were positively identified 
as K. pneumoniae by biochemical tests using differentiation media2, including Indole, 
Simmons citrate and Christensen’s urea agar, according to the manufacturer’s protocol 
(Remel, Lenexa, KS) (Figure 5-4C). 
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Chapter Three:  Multifactorial Patterns of Gene Expression in Colonic Epithelial 
Cells Predict Disease Phenotypes in Experimental Colitis 
 
Introduction 
Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and 
ulcerative colitis (UC), are thought to result from inappropriate inflammatory responses 
to normal components of the intestinal microbiota in genetically susceptible 
individuals113-115. Recent evidence has implicated both ineffective innate immune 
responses and overactive adaptive immune responses in the pathogenesis of IBD63-
68,113,114,116. Colonic epithelial cells (CEC) bridge innate and adaptive immune responses 
through cross-talk with luminal bacteria and with lamina propria immune cells65,113,114. 
There is a critical need to identify cellular and molecular biomarkers that can predict 
disease behavior and guide personalized therapy, and a number of candidates have been 
proposed89-93. Considering the complex etiology and the heterogeneous clinical 
presentation of IBD, we propose that a multifactorial approach offers significant 
advantages over the use of single biomarkers for diagnosis and treatment of IBD. 
Our group recently identified signature biomarkers in the colonic mucosa of CD 
patients that could be used in a multifactorial analysis to classify patients into molecular 
phenotypic subsets that were predictive of clinical characteristics and responses to 
therapy60. These biomarkers comprised 5 genes: the RelA subunit of NF-κB; A20, an 
ubiquitin-modifying enzyme that negatively regulates the NF-κB activation pathway; the 
polymeric immunoglobulin receptor (pIgR), which mediates epithelial transcytosis of IgA 
antibodies; the pro-inflammatory cytokine tumor necrosis factor (TNF), and the pro-
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inflammatory chemokine interleukin (IL)-8. The aim of the present study was to define 
patterns of biomarker gene expression that reflect the underlying mechanism and severity 
of intestinal inflammation. To this end we utilized two mouse models of colitis with very 
different etiologies. Oral administration of dextran sulfate sodium (DSS) induces acute 
colitis that is mediated primarily by effectors of innate immunity and causes damage to 
the epithelial barrier117. In contrast, adoptive transfer of naïve T cells into 
immunodeficient mice causes chronic colitis initiated by effector T cells and 
characterized by epithelial hyperplasia, goblet cell depletion and transmural 
inflammation99,118-120. We found different patterns of biomarker expression in these two 
models of experimental colitis that were predictive of disease severity. Importantly, 
down-regulation of expression and altered cellular localization of pIgR was a common 
feature of both colitis models. Furthermore, these defects were associated with failure to 
transport IgA. These results provide insights into the functions of CEC in regulation of 
intestinal inflammation, and provide proof of principle for the use of principal component 
analysis in the molecular diagnosis of intestinal inflammation.  
 
Results 
Assessment of disease severity in DSS and T cell-mediated colitis 
Acute colitis induced by oral administration of DSS resulted in significant weight 
loss, disease activity (diarrhea and blood loss) and pathological findings (colon 
shortening), with more severe symptoms in mice administered 3% DSS than 2% DSS 
(Figure 3-2 A, B). Tissue damage, including edema, goblet cell loss, ulcerations, 
epithelial cell destruction, and infiltration of inflammatory cells, was observed in all 
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DSS-treated mice and was more severe in mice treated with 3% DSS (Figure 3-2 C). 
Chronic colitis induced by adoptive transfer of CD4+CD45RBhiCD25- Teff cells (Figure 
3-1A) into Rag1-/- recipients resulted in a different clinical picture involving weight loss 
and an increased ratio of colon weight/length (Figure 3-2 D,E), but no symptoms of 
acute colitis such as diarrhea or blood loss (data not shown). Co-administration of 
CD4+CD45RBloCD25+ Treg with Teff corrected the clinical symptoms of T cell-
mediated colitis. Interestingly, colon tissues from control Rag1-/- mice exhibited a 
significantly shorter epithelial crypt length than did wild-type mice (compare Figure 3-2 
B and 2E) suggesting that the absence of B and T lymphocytes impaired normal 
development of the colonic epithelium. Adoptive transfer of Teff, with or without Treg, 
resulted in extensive crypt lengthening (Figure 3-2 F). Histological evidence of Teff-
mediated colitis included infiltration of lymphocytes and mononuclear cells into both the 
mucosa and submucosa, but fewer neutrophils. Some mucosal edema and epithelial 
damage was observed, but this was less severe than in acute DSS-mediated colitis mice 
(compare Figure 3-2 C and F). Co-administration of Treg with Teff resulted in a 
moderate reduction in the inflammatory infiltrate and lessened epithelial damage and 
mucosal edema.  
 
Differential expression of “signature” biomarkers in colonic epithelial cells in acute 
DSS-mediated and chronic T cell-mediated colitis 
We used these different models of experimental colitis to examine the relationship 
between the etiology of intestinal inflammation and gene expression in colonic ECs. 
Flow cytometry analysis of representative CEC preparations indicated that contamination 
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with CD45+ hematopoietic cells was on average less than 1% (Figure 3-1B). RNA was 
extracted from isolated ECs, and levels of mRNA were analyzed for 5 “signature” 
biomarkers that we have used to classify IBD patients into molecular phenotypic subsets 
60, i.e., RelA, A20, pIgR, TNF and MIP-2 (a functional homolog of human IL-8) (Figure 
3-3). While the overall patterns of biomarker expression varied considerably between 
DSS and T cell-mediated colitis, the one common feature was down-regulation of pIgR 
mRNA. Interestingly, co-administration of Treg with Teff prevented down-regulation of 
pIgR. These data are consistent with the notion that mucosal inflammation, independent 
of its cause, is sufficient to impair normal expression of pIgR. By contrast, down-
regulation of the RelA subunit of NF-κB was a more consistent feature of T cell-
mediated colitis than DSS colitis. Down-regulation of RelA in mice adoptively 
transferred with Teff was correlated with reduced expression of A20, a RelA target gene 
that is induced by the classical NF-κB pathway and acts as a negative feedback regulator 
of NF-κB activation 121. Co-administration of Treg with Teff did not restore RelA mRNA 
to control levels, but was sufficient to prevent down-regulation of A20. Finally, acute 
DSS colitis was characterized by strong up-regulation of the pro-inflammatory genes 
TNF and MIP-2 in CEC, which was not seen in chronic T cell-mediated colitis.  
 
Multifactorial patterns of biomarker expression predict disease phenotype  
It is clear that synergistic interactions among multiple gene products are involved 
in inflammatory responses, thus we used a multifactorial approach to identify patterns of 
gene expression that are associated with different etiologies of colitis. Factor analysis by 
the principal component (PC) method is a statistical approach that is used to reduce the 
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number of variables in a complex data set and to classify relationships between those 
variables. We previously used PC analysis, based on the 5 “signature” biomarkers 
described in Figure 2, to classify CD patients into molecular phenotypic subsets that were 
predictive of clinical disease 60. Here we demonstrate different patterns of gene 
expression associated with DSS and T cell-mediated experimental colitis in mice (Figure 
3-4). Chi-square analysis indicated that variability in the gene expression data sets for 
both DSS colitis and T cell transfer colitis could be reduced to two PCs (p < 0.0001) 
(Figure 3-4A). Eigen values indicated that the proportion of variance among mice in 
expression of these 5 variables that could be described by PC1 and PC2 together was 
72.5% for DSS colitis and 75.1% for T cell transfer colitis. The coefficients for each 
variable describe its relative contribution to PC1 and PC2. For both DSS colitis and T cell 
transfer colitis, PC1 was strongly weighted toward RelA, A20 and pIgR, with a negative 
weight for MIP-2. Interestingly, TNF had a minimal contribution to PC1 for DSS colitis, 
but contributed strongly to PC1 for T cell transfer colitis. PC2 was strongly weighted 
toward TNF and MIP-2 for both DSS colitis and T cell colitis. The relative contributions 
of RelA and A20 to PC2 differed for the two models, and pIgR did not contribute 
significantly to PC2 for either model. We conclude that the different patterns of epithelial 
gene expression reflect the different etiologies of DSS and T cell-mediated colitis and 
may be useful for predicting disease phenotype. To this end, each mouse was assigned a 
score for PC1 and PC2 based on the sum of the weighted expression levels for all 5 
biomarkers (see Materials and Methods for details) (Figure 3-4B). For the DSS model, 
PC1 scores did not vary significantly among treatment groups, whereas the score for PC2 
increased significantly with increasing DSS dose. Interestingly, the opposite pattern held 
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for T cell transfer colitis. Adoptive transfer with Teff resulted in a significantly lower 
PC1 score, which was prevented by co-administration of Treg, whereas no significant 
differences in PC2 scores were observed.  
To investigate whether these multifactorial PCs could predict disease severity, we 
performed linear regression analysis to examine the relationship between PC1 and PC2 
scores and clinical measures of disease (Figure 3-5). In the DSS colitis model, increased 
PC2 scores were significantly correlated with weight loss, decreased colon length (a 
measure of disease severity in DSS colitis),122 and tissue damage (quantified by 
histological score). A different pattern was observed for the T cell transfer colitis model, 
in which decreased PC1 scores were significantly correlated with weight loss and an 
increased ratio of colonic weight/length (a measure of disease severity in T cell transfer 
colitis). 99,118 However, tissue damage in this model was significantly correlated with 
increased PC2 scores, similar to the pattern seen in DSS-induced colitis. Taken together, 
these results suggest that a multifactorial approach combining the expression of multiple 
biomarkers in colonic EC can be used to discriminate among different mechanisms of 
inflammation and to predict disease severity. 
 
Colonic inflammation results in altered localization of pIgR and reduced epithelial 
transcytosis of IgA  
We previously reported that expression of pIgR and epithelial transcytosis of IgA 
were dysregulated in the colonic mucosa of Crohn’s disease patients60. Because down-
regulation of pIgR mRNA in CEC was a common feature of both DSS and T cell-
mediated colitis (Figure 3-3A, B), we hypothesized that epithelial transcytosis of IgA 
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would also be altered. Visualization of pIgR and IgA in sections of colonic tissue 
revealed reduced expression and aberrant localization of pIgR in the colonic epithelium 
in both DSS-induced (Figure 3-6A) and T cell-mediated colitis (Figure 3-6B). In 
untreated wild-type mice (Figure 3-6A, left panel), pIgR expression was abundant and 
predominantly localized to the lower two-thirds of the epithelial crypts. Significant co-
localization of pIgR and IgA was observed, consistent with normal transcytosis of IgA. 
However, in the colons of DSS-treated mice, pIgR staining was clearly reduced, 
consistent with reduced pIgR mRNA levels (Figure 3-3A), and was not concentrated in 
the lower section of the crypts. Importantly, we also observed less co-localization of IgA 
and pIgR in DSS-treated mice, although the presence of IgA-producing plasma cells in 
the lamina propria was increased. Similar to wild-type mice, pIgR was predominantly 
localized to the lower two-thirds of the epithelial crypts in control Rag1-/- mice (Figure 
3-6B). No IgA was detected in the colons of these mice, since they lack B cells and 
cannot produce IgA. Total pIgR staining was markedly reduced in the Rag1-/- mice 
adoptively transferred with Teff, consistent with down-regulation of pIgR mRNA 
(Figure 3-3B), and concentration of pIgR in the lower section of the crypts was not seen.  
Expression of pIgR was substantially restored when Treg cells were co-transferred with 
Teff (Figure 3-6B), consistent with the restoration of pIgR mRNA levels (Figure 3-3B). 
However, concentration of pIgR localization in the lower section of the crypts was not 
fully restored.  
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Discussion 
Molecular classification of IBD patients based on multifactorial patterns of 
biomarker expression offers the potential to personalize diagnosis and clinical 
management of this chronic and debilitating disease. Experimental mouse models of IBD 
have proven to be valuable tools for investigating mechanisms of IBD pathogenesis and 
for identifying potential therapeutic targets117,123. Oral administration of DSS causes 
concentration- and time-dependent cytotoxicity of intestinal epithelial cells, thus 
disrupting intestinal barrier function124. Because acute colitis could be induced by DSS in 
mice with severe combined immunodeficiency, which lack B and T lymphocytes125, it 
has long been thought that intestinal inflammation in this model is driven mainly by 
innate immune responses. However, more recent studies comparing DSS-induced colitis 
in immunodeficient and wild-type mice suggested that the presence of lymphocytes may 
exacerbate inflammation, particularly at low doses of DSS126. In the T cell transfer 
model, chronic colitis develops as a result of enteric antigen-driven activation, 
polarization and homeostatic expansion of naïve T cells to produce colitogenic Th1 
and/or Th17 effectors cells117, 118. Co-administration of T regulatory cells with T effector 
cells prevents induction of colitis, verifying a significant protective role for T regulatory 
cells in IBD pathogenesis99,127.  
Here we have focused on a limited set of 5 “signature” epithelial biomarkers that 
we previously validated for prediction of disease severity in CD patients60.  Given the 
heterogeneous clinical presentation in IBD, it is likely that a classification scheme based 
on multiple biomarkers will be more informative than the use of individual biomarkers. It 
is clear that the expression of many genes may change during intestinal inflammation. 
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However, by focusing on only 5 highly informative genes, we have provided proof of 
principle that a multifactorial approach can transform a limited amount of data into a 
potentially powerful diagnostic tool. We have now identified distinctive expression 
patterns of these 5 biomarkers expression in two models of experimental colitis with 
different etiologies (Figure 3-3). Principal component analysis reduced the 5 biomarkers 
into 2 multifactorial PCs that were specific for each model (Figure 3-4) and were 
predictive of disease severity (Figure 3-5). We propose that PC1 is a composite 
biomarker reflecting homeostatic epithelial barrier function, characterized by NF-κB-
stimulated physiological inflammation. The individual biomarkers RelA, A20 and pIgR 
were dominant contributors to PC1 in both colitis models. We previously reported that 
high expression of PC1 was associated with mild disease activity and good responses to 
therapy in CD patients60.  We found that high expression of pIgR was correlated with 
robust epithelial transcytosis of IgA. While excessive NF-κB signaling in immune cells 
has been implicated as a major contributor to intestinal inflammation and the 
development of IBD, NF-κB signaling in epithelial cells has been shown to promote 
intestinal homeostasis128-130.  Our finding of a potential protective role for NF-κB 
signaling is consistent with the report of Eckmann et al.33  in which ablation of the NF-
κB-activating kinase IKKβ in intestinal epithelial cells resulted in an exacerbation of 
DSS-induced colitis.  However, these investigators found that loss of epithelial IKKβ had 
no impact on chronic colitis that occurs spontaneously in IL-10-deficient mice. Thus the 
protective functions of epithelial-specific NF-κB signaling likely depend on specific 
etiology of intestinal inflammation. We found that epithelial expression of the pro-
inflammatory genes TNF and IL-8 (or mouse MIP-2, a functional homolog of human IL-
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8) contributed strongly to PC2. While a normal range of PC2 values is consistent with 
NF-κB-stimulated physiological inflammation, high PC2 values may indicate an 
excessive and damaging inflammatory response. Here we found that disease severity in 
acute DSS colitis was correlated with elevated PC2 values, with no significant alterations 
in PC1 values. These results are consistent with our previous findings in CD patients, 
where a subset of recently-diagnosed patients with elevated PC2 values and variable PC1 
values tended to present with acute inflammation that responded well to 
immunosuppressive and anti-TNF therapy60. In a recent analysis of these biomarkers in 
colonic biopsies of patients with UC, we observed a similar correlation between elevated 
PC2 values and acute inflammation (Bruno et al., unpublished data). These findings are 
significant in that many features of DSS colitis, such as  macroscopic appearance and 
histological injury, more closely resemble acute inflammation in UC than CD131. In 
contrast, we found that some measures of disease severity in chronic T cell-mediated 
colitis (weight loss, colon weight/length ratio) were correlated with low PC1 values, 
whereas tissue damage in the colon was associated with high PC2 values. This pattern is 
similar to that observed in subsets of CD and UC patients with low PC1 and variable PC2 
values, characterized by chronic inflammation and poor responses to immunosuppressive 
and anti-TNF therapy 60(Bruno et al., unpublished data) . The results of our current study 
suggest that acute colitis mediated by innate immune responses is associated with 
increased epithelial expression of pro-inflammatory genes, whereas chronic colitis driven 
by adaptive T cell responses is associated with diminished expression of genes associated 
with homeostatic epithelial barrier function. These findings provide insights into the role 
of epithelial cells in the regulation of colonic inflammation, and support the use of these 
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epithelial biomarkers for monitoring disease course and guiding therapy in IBD patients. 
We propose that multifactorial analysis of CEC gene expression may be valuable for 
monitoring the transition from acute to chronic colitis in IBD patients. This approach may 
enhance our understanding of immunological mechanisms underlying inflammation at 
different stages, which may require different therapeutic approaches, and may also help 
to identify patients at risk for sequelae associated with chronic inflammation, such as 
colitis-associated cancer. 
A novel finding that emerged from this study was that expression of pIgR in CEC 
was down-regulated in both acute DSS and chronic T cell colitis (Figure 3-3). 
Furthermore, DSS-induced inflammation was associated with reduced epithelial 
transcytosis of IgA (Figure 3-6A). These results were consistent with our findings in CD 
patients with either acute or chronic colitis, in which expression of pIgR and transcytosis 
of IgA in CEC was reduced compared to normal individuals or CD patients with mild 
disease60. The importance of pIgR in prevention of intestinal inflammation is supported 
by the report that pIgR-deficient mice were more susceptible to DSS-induced colitis than 
were wild-type mice58. pIgR transports polymeric IgA from the basal to the apical surface 
of intestinal epithelial cells, where proteolytic cleavage of the extracellular domain of 
pIgR (secretory component, SC) releases secretory IgA (SIgA) into the intestinal 
lumen44,132. Because one molecule of pIgR is synthesized for every molecule of IgA 
transported, the level of pIgR expression controls the rate of epithelial transcytosis of 
IgA. SIgA antibodies play a critical role in shaping the composition of the gut microbiota 
and in maintenance of intestinal homeostasis45. SIgA binds to intestinal mucus via 
glycan-mediated interactions, thus forming an immunological barrier to penetration of the 
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epithelial layer by microbes and environmental antigens, and can also neutralize antigens 
and microbial products intracellularly during pIgR-mediated epithelial transcytosis.  In 
addition, pIgR can transport IgA-containing immune complexes across polarized IEC 
monolayers, thus disposing of antigens through a non-inflammatory process 133. Thus, 
reduction of pIgR expression during colitis would be predicted to diminish not only the 
antimicrobial function of luminal SIgA, but also removal of IgA-bound antigens from the 
lamina propria.  These defects would exacerbate local inflammation and increase the 
level of IgA immune complexes,  a potential risk factor for development of IgA 
nephropathy, which has been linked with IBD88. 
It should be noted that a protective role for pIgR in the T cell transfer model of 
colitis could not involve transcytosis of SIgA, since B cell-deficient recipient Rag1-/- 
mice do not produce IgA. However, it is well known that free SC, which is released when 
pIgR that is not associated with IgA is cleaved at the apical surface of epithelial cells, 
contributes to intestinal homeostasis by inhibiting bacterial adherence to the intestinal 
mucus layer and neutralizing of potential pro-inflammatory factors54,134. We found that 
expression of pIgR mRNA was reduced (Fig. 2B) and the cellular localization of pIgR 
protein was aberrant (Fig. 5B) in Rag1-/- mice adoptively transferred with Teff. 
Importantly, co-administration of Treg prevented both of these defects. Taken together, 
our results suggest that inflammation in the colon, whether due to innate immune 
responses in the DSS model or adaptive immune responses in the T cell model, creates a 
local environment that is not conducive to optimal expression and cellular trafficking of 
pIgR.  
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We found that epithelial expression of TNF was significantly increased in acute 
DSS colitis (Fig. 2A) and contributed strongly to pro-inflammatory PC2, but not to 
homeostatic PC1 values (Figure 3-4A). In contrast, altered epithelial expression of TNF 
was not a feature of T cell-mediated chronic colitis (Figure 3-3B) and contributed to both 
PC1 and PC2 values (Figure 3-4A). Although TNF expression was not elevated in CEC 
of mice with T cell-mediated colitis, we cannot rule out the possibility that production of 
TNF by other cell types contributes to intestinal inflammation in this model. We 
previously reported that expression of TNF in mucosal biopsies (which contain stromal 
and bone marrow-derived cells in addition to epithelial cells) was actually reduced in a 
large subset of CD patients with longstanding, chronic inflammation60. We recently 
reported that stimulation with TNF enhances expression of pIgR through a RelA-
dependent mechanism in a human CEC line 135, suggesting that physiological production 
of TNF in the colonic epithelium may contribute to intestinal homeostasis by promoting 
pIgR-mediated transcytosis of SIgA and innate immune functions of SC.  However, 
failure to regulate TNF production clearly contributes to the pathogenesis of IBD. 
Biological therapies designed to neutralize TNF have been extremely useful in managing 
severe colitis136, and a recent report suggests that anti-TNF therapy may promote the 
activation and expansion of T regulatory cells in CD patients137.  However, neutralization 
of TNF can be associated with significant adverse effects, including exacerbation of 
disease, serious infection and malignancies. Furthermore, anti-TNF therapies are only 
effective in about half of patients, and there are as yet no clear clinical guidelines 
regarding which anti-TNF drug to use first or how to manage patients who experience 
recurrence of symptoms138.  Our findings in CD patients and in experimental models of 
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colitis suggest that monitoring TNF expression in the colonic mucosa may be useful for 
understanding disease mechanisms and identifying those patients most likely to benefit 
from anti-TNF therapy. 
 
 
 
  
58 
 
 
Figure 3-1 Purification of T cells and colonic epithelial cells (CECs).  T effector and T 
regulatory cell populations for T cell transfer model of experimental colitis. (A) Single 
cell suspensions of spleens from wild-type mice were separated into CD4+CD45RBhi 
(fraction R3) and CD4+CD45RBlo fractions (fraction R4) by fluorescence-activated cell 
sorting. (B) The histogram shows intensity of cell surface CD25 staining in the 
CD4+CD45RBhi (black) and CD4+CD45RBlo (purple) fractions. (C) Purity of colonic 
epithelial cells (CEC). Isolated CECs were analyzed for cell surface CD45 by flow 
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Figure 3-1 (continued) cytometry. The major peak in each plot represents ECs, and the 
gated area represents contaminating small CD45hi hematopoietic cells. (Frantz et al. 
Multifactorial Patterns of Gene Expression in Colonic Epithelial Cells Predict Disease 
Phenotypes in Experimental Colitis. Inflammatory Bowel Disease in press 2012.) 
Reprinted with permission. 
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Figure 3-2 Assessment of disease severity in DSS and T cell transfer colitis. DSS 
colitis. Mice were left untreated or administered 2% or 3% DSS in the drinking water for 
8 days. (A) Changes in body weight (expressed as a percentage of weight at the 
beginning of the experiment) and disease activity (see Materials and Methods for an 
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Figure 3-2 (continued) explanation of the disease activity index). Data from 1 of 3 
independent experiments with similar results are expressed as mean ± SEM (n = 8). (B) 
Colon lengths were measured on day 8; data combined from 3 independent experiments 
are expressed as mean ± SEM (n = 16). (A, B) One asterisk indicates that the mean is 
significantly different from the mean for control mice, and two asterisks indicate that the 
mean is significantly different from the mean for both control mice and mice treated with 
2% DSS (p < 0.05). (C) Colon histology from representative mice at day 8. Images of 
formalin-fixed colon tissues stained with hematoxylin and eosin were captured with a 
20X objective. (D-F) T cell transfer colitis. Rag1-/- mice were left untreated (control) or 
adoptively transferred with 4 x 105 CD4+CD45RBhiCD25- T-effector cells (Teff), with or 
without 1 x 105 CD4+CD45RBloCD25+ T-regulatory cells (Treg). (D) Changes in body 
weight; data from 1 of 3 independent experiments with similar results are expressed as 
mean ± SEM (n = 8). (E) Colons were measured and weighed at 10 weeks post-transfer; 
data are expressed as mean ± SEM (n = 10). (D, E) An asterisk indicates that the mean is 
significantly different from the mean for control Rag1-/- mice (p < 0.05). (F) Colon 
histology from representative mice at 10 weeks post-transfer. Images of formalin-fixed 
colon tissues stained with hematoxylin and eosin were captured with a 20X objective. 
(Frantz et al. Multifactorial Patterns of Gene Expression in Colonic Epithelial Cells 
Predict Disease Phenotypes in Experimental Colitis. Inflammatory Bowel Disease in 
press 2012.) Reprinted with permission. 
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Figure 3-3 Comparison of biomarker expression in colonic ECs in experimental 
colitis: (A) DSS colitis; (B) T cell transfer colitis. Colitis was induced as described in 
Figure 1, and colonic ECs were isolated at the end of the experiments. mRNA levels were 
measured by qRT-PCR and normalized to β2-microglobulin mRNA. For each model, 
data from 3 independent experiments were combined and expressed as mean ± SEM (n = 
16 for DSS colitis and n = 10 for T cell transfer colitis). Asterisks indicate that the mean 
for treated mice is different from the mean for control mice (p < 0.05). (Frantz et al. 
Multifactorial Patterns of Gene Expression in Colonic Epithelial Cells Predict Disease 
Phenotypes in Experimental Colitis. Inflammatory Bowel Disease in press 2012.) 
Reprinted with permission.  
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Figure 3-4 Multifactorial analysis of biomarker expression patterns in experimental 
colitis, using data described in Figure 2 for mRNA levels in colonic ECs. (A) Factor 
analysis was used to reduce data for 5 variables, NF-κB, RelA, A20, pIgR, TNF and 
MIP-2, into two principal components (PCs). Eigen values indicate the proportion of 
variance among mice in expression of these 5 variables that can be described by PC1 and 
PC2. Weighted coefficients are listed for each variable comprising PC1 and PC2. (B) 
PC1 and PC2 scores were calculated for each individual mouse based on the sum of 
normalized expression levels for each variable multiplied by its corresponding coefficient 
for PC1 and PC2 (see Materials and Methods). Combined data from 3 independent 
experiments for each mouse model are expressed as mean ± SEM (n ≤ 14 mice/group for 
DSS colitis and n = 10 mice/group for T cell transfer colitis). Asterisks indicate that the 
mean PC values for the indicated comparisons are significantly different (p < 0.05); NS = 
not significant.  Reprinted with permission. 
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Figure 3-5 Expression of colonic epithelial biomarkers predicts disease severity in 
experimental colitis: (A) DSS colitis; (B) T cell transfer colitis. Plots depict linear 
regression comparing PC1 and PC2 scores for each mouse to body weight at the end of 
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Figure 3-5 (continued) the experiment, and colon length (DSS colitis) or the ratio of 
colon weight to length (T cell transfer colitis). Correlation coefficients (r) and P-values 
(p) are listed for each regression line. (Frantz et al. Multifactorial Patterns of Gene 
Expression in Colonic Epithelial Cells Predict Disease Phenotypes in Experimental 
Colitis. Inflammatory Bowel Disease in press 2012.) Reprinted with permission. 
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Figure 3-6 Localization of pIgR and IgA in colonic mucosa of mice with 
experimental colitis: (A) DSS colitis; (B) T cell transfer colitis. Sections of formalin-
fixed colons were stained by immunofluorescence for pIgR (green), IgA (red) and nuclei 
(DAPI; blue). Representative images are shown for each treatment group. Images were 
captured with a 25X objective.  (Frantz et al. Multifactorial Patterns of Gene Expression 
in Colonic Epithelial Cells Predict Disease Phenotypes in Experimental Colitis. 
Inflammatory Bowel Disease in press 2012.) Reprinted with permission. 
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 Chapter Four: Regulation of pIgR expression by commensal bacteria in human 
intestinal epithelial cells   
 
Introduction 
The mammalian gut is home to an estimated one trillion bacteria and it is the 
responsibility of the intestinal epithelium to separate this vast number of bacteria from 
host tissue6.  Secretory IgA antibodies, transported across intestinal epithelial cells (IEC) 
by the polymeric immunoglobulin receptor (pIgR), provide the first line of defense 
against potentially harmful bacteria44,132.  This transport process provides multiple levels 
of immune protection: Excretion of IgA-containing immune complexes; transcytosis of 
SIgA has been shown to neutralize viruses and microbial products within IEC55; release 
of SIgA at the apical surface of the epithelium serves as a physical barrier, limiting 
bacterial adherence translocation44,56; and secretory component, the cleaved extracellular 
domain of pIgR,  unbound to IgA has been shown to contribute to innate immunity by 
acting as a non-specific bacterial scavenger and limiting inflammatory immune 
response54. One molecule of pIgR is consumed for every molecule of SIgA transported 
into the lumen, thus the rate of pIgR transcription controls the rate of SIgA transcytosis 
and high expression of pIgR is required to maintain sufficient supply of SIgA and SC44. 
Accordingly, steady-state levels of pIgR mRNA in mouse and human IEC are very high. 
We have shown that expression of pIgR is much higher in the colon than in the ileum of 
both healthy controls and CD patients, which is likely due to enhanced bacterial 
stimulation of IECs due to greater numbers of commensal bacteria60. However, the 
mechanisms by which IEC maintain high levels of pIgR expression while limiting 
69 
 
inflammatory immune responses in the face of the vast microbial community are not 
completely understood.  Therefore the aim of this chapter is to dissect the molecular 
mechanism by which pIgR expression is regulated in IEC by commensal bacteria and 
compare this to the regulation of the pro-inflammatory response.   
Cross-talk between commensal bacteria and IEC is mediated by pattern-
recognition receptors, including Toll-like receptors (TLRs)6.   While TLR signaling is 
capable of triggering inflammation in response to microbial insult, these innate immune 
receptors establish intestinal homeostasis by discriminating between symbiotic 
commensal bacterial and harmful pathogens6. Accordingly, IEC TLR signaling identifies 
the composition of the local microbiota and instructs the underlying effector and 
regulatory immune cells, with the ultimate function to dampen inflammation while 
providing immune protection6,139,140. This process involves production and transport of 
large quantities of IgA in order to maintain this balance140. Previous studies from our lab 
have demonstrated that stimulation of TLR3 and TLR4 with purified ligands induces 
pIgR expression in IEC in vitro141.  TLRs that sense microbial components require the 
cytoplasmic adaptor protein, MyD88 to activate downstream signaling pathways. MyD88 
deficiency results in significant impairment of intestinal IgA responses and 
homeostasis62,142. However, the role of IEC MyD88-dependent TLR signaling in the 
regulation of pIgR expression is unclear.   
MyD88-dependent TLR signaling leads to the activation of nuclear factor –κB 
(NF-κB)27 signaling pathways and parallel activation of several mitogen-activated protein 
kinases (MAPK) including c-Jun N-terminal kinase (JNK), extracellular signal-regulated 
kinase ERK (ERK), and p38 MAPK26. Accordingly, NF-κB and MAPK activation is 
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significantly reduced in MyD88-deficient mice28. However, the contributions of these 
pathways in the induction of pIgR by bacterial stimulation have not been investigated. 
The NF-κB family of transcription factors consists of five members in mammals, RelA, 
RelB, c-Rel, p50 and p5231.  These NF-κB proteins can form homo- or heterodimers that 
bind DNA consensus sequences on target genes to regulate gene transcription. Inactive 
NF-κB is localized to the cytoplasm in association with IκB inhibitory proteins.  
However, upon stimulation, phosphorylation and degradation of IκB proteins occurs, 
resulting in the nuclear translocation of NF-κB dimers30.  Two NF-κB signaling 
pathways have been identified. The classical RelA-dependent pathway is activated 
primarily by pro-inflammatory cytokines and TLR ligands, leading to the degradation of 
IκBa and the nuclear translocation of RelA/p50 heterodimers31.   The translocation of 
RelA/p50 into the nucleus leads to the activation of gene transcription, including the 
rapid induction of several pro-inflammatory chemokines and cytokines, such as IL-8 and 
TNF, which comprise the early pro-inflammatory response143.   This early pro-
inflammatory response is quickly downregulated by negative regulators within hours of 
induction144.   In contrast, the induction of pIgR by pro-inflammatory cytokines and TLR 
ligands is slow and sustained, peaking at 24 hours and remaining high141,143. The 
alternative NF-κB pathway is primarily activated by a limited number of stimuli 
including lymphotoxin B and B-cell activating factor (BAFF) and involves the nuclear 
translocation of RelB/52 dimers31,145.  Although NF-κB signalling in the intestine has 
been studied extensively, the differential roles of the classical RelA-dependent or the 
alternative RelB-dependent pathway are not fully understood due to its complex nature 
and the intrinsic variability in different cell types146.  Our lab has previously 
71 
 
demonstrated that transcription of the PIGR gene, in response to TNF and TLR signaling, 
requires a κB element in the first intron that is a perfect match to the RelA consensus 
sequence147. Additional studies using siRNA have shown that de novo synthesis of RelB 
is required for optimal TNF-mediated induction of pIgR148.   This chapter will investigate 
the contributions of the classical and alternative NF-κB pathways in the induction of 
pIgR transcription under the hypothesis that these factors may have differential roles in 
the maintenance of pIgR expression and the induction of pro-inflammatory immune 
responses. By utilizing chemical inhibitors and intestinal epithelial cell lines in which the 
expression of critical components of these signaling pathways are knocked down, 
stimulus-specific mechanistic differences in the regulation of pIgR and pro-inflammatory 
gene expression in intestinal epithelial cells are examined.  
 
Results 
Activation of the NF-κB pathway by TNF and TLR signaling is required to induce 
pIgR expression.   
To determine if the RelA-dependent NF-κB pathway is required for the induction 
of pIgR expression, the human IEC line HT-29 cells was stimulated with TNF or ligands 
for TLR4 (lipopolysaccharide (LPS)) or TLR3 (polyinosinic:polycytidylic acid (pIC)), in 
the presence or absence of BAY 11-7082, an inhibitor of IκBa phosphorylation (Figure 
4-1).  Consistent with previous reports from our lab using this cell line, IL-8 mRNA 
levels rapidly increased following 3 hours of stimulation with TNF or TLR ligands, 
indicative of the early pro-inflammatory response.  Likewise, induction of IL-8 by all 
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three ligands was inhibited by BAY11-7082, suggesting that this early pro-inflammatory 
response induced by TNF and TLR signaling in IECs involves the classical NF-κB 
pathway. The varying magnitude of IL-8 induction by TNF, LPS and pIC, as well as the 
varying degree of IL-8 inhibition in the presence of BAY 11-7082, suggests that NF-κB 
activation may be stimulus-specific and/or there may be additional contributions from 
other signaling pathways in the regulation of the early pro-inflammatory response. 
Alternatively, induction of pIgR was delayed until 24 hours of TNF or TLR stimulation, 
consistent with previous published results from our lab, and the magnitude of induction 
was similar for all three stimuli. Additionally, pIgR induction in response to all three 
stimuli was completely inhibited in the presence of BAY 11-7082B, indicating that pIgR 
induction by TNF and TLR signaling requires activation of the classical NF-κB pathway. 
These results are not specific to the HT-29 cell line because similar results were observed 
when using another human IEC line, LoVo cells (Figure 4-2). Other colon carcinoma 
cell lines, including CaCo2, SW480 and LS174T, were also tested (data not shown); 
however, while similar NF-κB-dependent gene expression was observed in these cell 
lines, pIgR mRNA levels were extremely variable. Therefore, since HT-29 cells are a 
well established model for studying IEC responses and the regulation of pIgR, all 
additional in vitro cell culture experiments have been performed using HT-29 cells.  Our 
lab has previously demonstrated that changes in mRNA levels in response to various 
stimuli are directly proportional to changes in protein expression for pIgR and IL-8 in 
HT-29 cells. Taken together, these results suggest that the early pro-inflammatory 
response and the delayed induction of pIgR expression in human IECs require activation 
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of the classical NF-κB pathway, yet the contributions of the RelA-dependent NF-κB 
pathway in these responses may be different. 
 
Differential contributions of the classical NF-κB pathway to the induction of early 
inflammatory response genes and the induction of pIgR expression 
 To investigate the mechanisms that regulate the early induction of pro-
inflammatory genes and the delayed induction of pIgR in IEC by TNF and TLR 
signaling, control, RelA and RelB knockdown cells were stimulated with TNF, LPS or 
pIC for 3 and 24 hours (Figure 4-3). The early pro-inflammatory response, characterized 
by the induction of IL-8 and TNF expression, was significantly inhibited in the RelA 
knockdown cells, particularly in response to TLR signaling. Knockdown of RelA also 
inhibited the induction of A20, the cytoplasmic ubiquitin-editing enzyme that acts as a 
negative feedback regulator of the classical NF-κB pathway. While, knockdown of RelB 
had little effect on the induction of gene expression in response to LPS or pIC 
stimulation, RelB knockdown partially inhibited TNF-stimulated induction of early 
response genes, indicating an involvement of the alternative NF-κB pathway.  
Knockdown of RelA inhibited the late induction of pIgR in response to TNF 
stimulation but not to stimulation by TLR ligands.  Interestingly, the steady-state levels 
of pIgR mRNA were significantly higher in RelB knockdown cells, as compared to 
control and RelA knockdown cells, indicating a potential inhibitory effect of RelB on 
pIgR expression. Accordingly, RelB knockdown did not inhibit the up-regulation of pIgR 
expression in response to any stimuli, but further increases in pIgR mRNA were observed 
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upon stimulation. Taken together, these results suggest that the classical RelA-dependent 
NF-κB pathway is required for the regulation of pIgR expression by TNF signaling, 
however additional signaling pathways may be able to compensate to promote the 
induction of pIgR in response to TLR signaling. To ensure that inhibition of RelA by 
siRNA did not have indirect effects on the MAPK signaling pathway, the expression of 
MAPK-phosphotase 1 (MKP-1) was analyzed.  MKP-1, the phosphotase that 
downregulates MAPK signaling, contains multiple MAPK-responsive elements in its 
promoter region, but it does not contain any κB-binding sites and should not be directly 
affected by NF-κB inhibition. Accordingly, only minor changes in MKP-1 levels were 
observed in RelA or RelB knockdown cells, suggesting the NF-κB knockdown did not 
significantly affect MAPK signaling. 
 
Differential contributions of the MAPK signaling pathway in the regulation of the 
early pro-inflammatory response and the polymeric immunoglobulin receptor 
  It has been well established that stimulation of TNF and TLR signaling leads to 
the activation of not only NF-kB signaling, but additional signaling pathways, including 
MAPK signaling.  To investigate the role of MAPK signaling in regulating expression of 
early pro-inflammatory genes and the late induction of pIgR in response to TNF and TLR 
signaling, HT-29 cells were stimulated with TNF, LPS or pIC in the presence of 
individual MAPK inhibitors (inhibitors to p38, JNK, and ERK) or a combination of all 
three inhibitors (Figure  4-4). Inhibition of p38 and ERK signaling significantly reduced 
the induction of IL-8 in response to TNF and pIC, while inhibition of JNK had no effect 
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on this early pro-inflammatory response.  Likewise, the combination of all three MAPK 
inhibitors prevented the induction of IL-8 in response to all three stimuli, suggesting that 
these MAPK pathways work synergistically to regulate the early pro-inflammatory 
response. Alternatively, inhibition of MAPK signaling did not inhibit the induction of 
pIgR, rather, inhibition of p38 as well as a combination of all three inhibitors actually 
enhanced induction of pIgR in response to TNF and pIC.  These results are consistent 
with previous work that demonstrated that TNF-induced expression of pIgR in HT-29 
cells was enhanced when ERK activation was inhibited. Induction of pIgR by LPS was 
not affected by any MAPK inhibitors149.  Taken together, these results suggest that 
MAPK signaling, while stimulus-specific, plays different roles in regulating the early 
pro-inflammatory response and the late induction of pIgR.  Specifically, MAPK signaling 
pathways act synergistically to enhance expression of pro-inflammatory genes, while 
inhibiting the late induction of pIgR. 
 
pIgR expression is regulated by TLR4 signaling in intestinal epithelial cells 
These results indicate that multiple signaling pathways may function to maintain 
pIgR expression in IECs, particularly in response to bacterial-induced TLR signaling. 
However, it is generally accepted that IEC are “hyporesponsive” to constant stimulation 
with intestinal bacteria, maintaining immune tolerance to prevent excessive 
inflammation6,17. This idea is supported by the observation from our lab that when 
stimulated with various species representing the four major phyla of colonic bacteria, 
HT-29 cells only responded to stimulation from bacteria in the family 
Enterobacteriacceae62. To investigate the mechanism underlying the hyporesponsiveness 
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of intestinal epithelial cells to commensal bacteria and the maintenance of pIgR 
expression, HT-29 human intestinal epithelial cell line and THP-1 human monocyte cell 
line were stimulated with purified E. coli (Enterobacteriaceae family) LPS, a ligand for 
TLR4, and Pam3CSK4, a ligand for TLR2. These ligands were chosen due to their ligand 
preferences and spatially restricted expression by IECs. While TLR2, TLR4 and TLR5 all 
recognize bacterial components and are expressed on the epithelial surface of IECs, 
TLR4 and TLR2 have been shown to be expressed on the apical surface of epithelial 
cells, as opposed to TLR5 which is only expressed on the basolateral surface of IECs6. 
Consistent with previous published work, pIgR expression was induced upon activation 
of TLR4 (Figure 4-5A).  However, induction of pIgR was not observed in response to 
TLR2 activation.   The unresponsiveness to PamCSK4 stimulation was not gene specific 
because IL-8 expression was not induced upon TLR2 signaling, but was significantly 
induced in response to TLR4 signaling in HT29 cells (Figure 4-5B).  In contrast, THP-1 
monocytes induced very high levels of IL-8 mRNA in response to either TLR2 or TLR4 
signaling.  One possible explanation for the hyporesponsiveness of HT-29 cells to TLR2 
stimulation is the observation that THP1 cells express 2000-fold higher levels of TLR2 
mRNA than HT-29 cells.  Alternatively expression of TLR4, as well as the cytoplasmic 
adaptor protein MyD88, was relatively similar between the IEC and monocyte cell-lines 
(Figure 4-5).  To determine whether the hyporesponsiveness of IEC was due to the 
inhibition of TLR signaling, the expression of TLR signaling inhibitors, the TLR decoy 
receptor, Single Ig IL-1-related receptor (SIGIRR) and the Toll-interacting protein 
(TOLLIP), a cytoplasmic protein that binds to the intracellular domains of TLRs to 
inhibit IRAK phosphorylation and downstream signaling, were analyzed.  The basal level 
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of SIGIRR was 3-fold higher in HT-29 cells, compared to THP-1 cells, and expression of 
this TLR inhibitor was not downregulated in response to TLR signaling in HT-29 cells, 
as observed in THP-1 cells.  Likewise, while the basal level of TOLLIP was slightly 
lower in HT-29 cells, expression of this TLR inhibitor was significantly upregulated in 
response to TLR stimulation, which was not observed in THP-1 cells. Taken together, 
these results suggest that the hyporesponsiveness of IEC to colonic bacteria may be a 
result of reduced TLR2 signaling as well as the upregulation of TLR signaling inhibitors.  
To investigate the hypothesis that pIgR induction by commensal bacteria is 
dependent on TLR4 signaling, HT-29 cells were stimulated with E.coli strain Nissle 
(EcN) for 24 hours in the presence of increasing concentrations of polymixin B, an 
antibiotic that neutralizes LPS, inhibiting activation of TLR4 (Figure 4-6). Accordingly, 
while EcN stimulation significantly induced pIgR expression, this induction was 
inhibited in a dose-dependent manner in the presence of polymixin B.  These results 
indicate induction of pIgR by colonic bacteria is primarily dependent on the activation of 
TLR4 signaling by LPS. 
 
 Gene expression induced by colonic bacteria is dependent on intestinal epithelial 
MyD88 signaling 
  Ligation of TLR4 leads to the recruitment of the cytoplasmic adaptor protein 
MyD88.  We have recently reported that the steady-state levels of pIgR mRNA was 
significantly reduced in MyD88 deficient mice62. However, in this study it was not 
determined whether pIgR expression was regulated directly by MyD88 signaling in IEC 
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or indirectly by immune cells in the lamina propria62.  To investigate the hypothesis that 
MyD88 signaling in IEC regulates pIgR expression in response to colonic bacteria, HT-
29 cells were stably transfected with shRNA directed against MyD88, or an irrelevant 
control.  Significant knockdown of MyD88 expression was achieved in shRNA 
transfected cells (Figure 4-7).  Stimulation with EcN for 3 hours upregulated MyD88 
expression in both control and MyD88 knockdown cells, but the expression of MyD88 in 
the knockdown cells was less than unstimulated control cells. Likewise, EcN induced 
expression of IL-8, which peaked at 3hrs in control transfected cells, but this induction 
was significantly inhibited in MyD88 knockdown cells. Similarly, EcN induced pIgR 
expression by 24 hours in control transfected cells, but induction of pIgR was 
significantly inhibited in MyD88 knockdown cells.  Furthermore, correlation analysis 
revealed a strong positive correlation between MyD88 expression and IL-8 and pIgR 
expression.  These results suggest that the induction of both IL-8 and pIgR in response to 
commensal bacteria is dependent on intestinal epithelial MyD88 signaling. 
 
Induction of pIgR by E. coli is dependent on NF-κB signaling, but not MAPK 
signaling 
 Activation of MyD88-dependent TLR signaling leads to the activation of the NF-
κB and MAPK signaling pathways, resulting in the induction of gene expression. To 
investigate the contribution of these downstream signaling pathways to the induction of 
early pro-inflammatory genes and late pIgR expression in response to colonic bacteria, 
HT-29 cells were stimulated for 3 or 24 hours in the presence or absence of Bay 11-7082, 
an inhibitor of NF-κB, or inhibitors to the MAPK signaling pathways.  Inhibition of NF-
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κB activation completely inhibited the induction of both IL-8 and pIgR in response to E. 
coli stimulation (Figure 4-8A), suggesting NF-κB signaling is required to induce IL-8 
and pIgR expression in response to colonic bacteria.  To determine the contributions of 
RelA and RelB in the induction of IL-8 and pIgR in response to colonic bacteria, RelA a 
RelB knockdown cells were stimulated with EcN for 3 or 24 hours (Figure 4-8B).  
Inhibition of RelA significantly reduced the induction of IL-8, while inhibition of RelB 
had no effect.  Alternatively, inhibition of either RelA or RelB had no effect on the 
upregulation of pIgR in response to EcN.  These results indicate that while IL-8 induction 
is dependent on the classical RelA pathway of NF-κB activation, RelA and RelB may be 
interchangeable for the induction of pIgR by colonic bacteria. Inhibition of the p38 
MAPK pathway, but not the ERK or JNK MAPK pathway, significantly reduced the 
induction of IL-8 by EcN (Figure 4-9).  However, none of the MAPK inhibitors had any 
effect on the induction of pIgR by EcN (Figure 4-9).  Taken together, these findings 
suggest that while both the early pro-inflammatory response and the late pIgR response 
requires MyD88-dependent TLR4 signaling in IEC, these responses have distinct 
downstream signaling requirements. The activation of the early pro-inflammatory genes 
in response to EcN is dependent on activation of p38 and the classical RelA-dependent 
NF-κB pathway, while the late induction of pIgR requires NF-κB activation, but is 
independent of MAPK signaling. 
 
Discussion 
The function of NF-κB signaling in the intestine epithelium is complex. A 
balance of inflammatory and anti-inflammatory immune responses must be maintained to 
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ensure adequate protection against potential pathogens while preventing collateral 
damage to the intestinal epithelium30.  Several mouse models support the idea that 
hyperactivation of NF-κB contributes to intestinal inflammation.  In particular, mice 
lacking epithelial-specific expression of SIGIRR, the negative regulator of TLR-
dependent NF-κB activity, develop much more severe DSS-induced colonic 
inflammation82. These results suggest that bacterial-induced hyperactivation of NF-κB 
could be sufficient for promoting intestinal inflammation and maintaining a level of NF-
κB hyporesponsiveness may be beneficial in response to significant bacterial stimulation.   
On the other hand, ablation of NF-κB in the intestinal epithelium is also associated with 
inflammation. Loss of epithelial-specific NF-κB activity by deletion of epithelial-NEMO 
causes severe spontaneous colitis in mice34. Mice with a targeted deletion of Rela in IECs 
exhibited reduced expression of pro-restitution genes, increased epithelial apoptosis and 
increased susceptibility to DSS-induced acute colitis30. Furthermore, while individual 
ablation of IKK1 or IKK2 in IECs is insufficient to cause spontaneous inflammation¸ 
mice deficient in both IKK1 and IKK2 develop colitis similar to epithelial-specific 
NEMO-deficient mice34; thus, the classical NF-κB pathway, or at least functional IKK1 
or IKK2, is essential in maintaining intestinal homeostasis. Accordingly, these new 
findings presented here suggest that regulation of pIgR expression in IECs may be an 
important mechanism by which NF-κB maintains intestinal homeostasis during pro-
inflammatory immune responses. Here we show that while the induction of pIgR by 
soluble ligands, including TNF and TLR ligands, is dependent on NF-κB signaling, the 
specific contributions of the classical and alternative NF-κB pathways are stimulus 
specific. In particular, by inhibiting RelA expression, we demonstrated that the TNF-
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stimulated upregulation of pIgR expression requires the classical NF-κB signaling 
pathway.  These results are supported by the abolishment of transcriptional activity of a 
PIGR reporter gene in these RelA knockdown HT-29 cells in response to TNF 
stimulation105. Alternatively, the regulation of pIgR expression by TLR signaling appears 
to involve both the classical and alternative NF-κB pathways. Similar to TNF 
stimulation, inhibiting IκBα phosphorylation significantly inhibited pIgR induction in 
response to LPS and pIC, which is supported by the observation that the transcriptional 
activity of a PIGR reporter gene was significantly reduced in RelA knockdown HT-29 
cells105. However, knockdown of either RelA or RelB did not inhibit the induction of 
pIgR mRNA levels following LPS or pIC stimulation.  These results suggests that the 
classical and alternative NF-κB signaling pathways, as well as additional pathways, may 
be able to compensate for the loss of either RelA or RelB in order to maintain pIgR 
expression in the presence of bacterial stimulation.  
Although our results suggest that additional signaling pathways may contribute to 
the regulation of pIgR expression, inhibition of MAP kinases, which are known to be 
activated by TNF and TLR signaling, did not block induction of pIgR.  In particular, 
inhibition of ERK activation actually increased pIgR expression, which is consistent with 
previous reports149.  In contrast, MAPK activation was required for the early induction of 
IL-8 expression, highlighting the mechanistic differences in the regulation of the early 
pro-inflammatory response and the slow and sustained induction of pIgR expression. 
Taken together, these results suggest that the regulation of pIgR expression in intestinal 
epithelial cells may be an important mechanism by which NF-κB maintains intestinal 
homeostasis during pro-inflammatory responses. Furthermore, by utilizing signaling 
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pathways that are distinct from those involved in regulating the early pro-inflammatory 
response, IECs are able to upregulate pIgR expression in response to microbial and host 
stimuli while suppressing a potentially damaging pro-inflammatory response. 
This hyporesponsiveness, or suppression of pro-inflammatory responses, by IECs 
in response to bacterial stimulation is highlighted by the observation that HT-29 cells 
respond to purified LPS and whole EcN, although not as robustly as the THP-1 monocyte 
cell lines.  Alternatively, HT-29 cells were unresponsive to TLR2 stimulation, unlike 
THP-1 cells.  Consistent with these results, we found that while IECs express very low 
levels of TLR2, expression of TLR4 and MyD88 is similar between cell types and are 
upregulated by pro-inflammatory stimuli. Furthermore, induction of pIgR by whole E. 
coli was primarily dependent on the TLR4-activation of MyD88 signaling.  Interestingly, 
studies examining the structural requirements for TLR4-mediated signaling indicate that 
LPS molecules from only a limited group of Gram-negative bacteria, specifically those of 
the family Enterobacteriaceae, have the ability to act as a TLR4 ligand150,151. LPS 
molecules from other Gram-negative commensal bacteria signal through TLR2 rather 
than TLR4152. Unlike TLR2 expression, which remained low following stimulation with 
PAM3CSK4, TLR4 expression was upregulated in response to E. coli LPS.  Moreover, it 
has previously been demonstrated that IgA can neutralize E. coli LPS within IECs56. 
Taken together, these results suggests a negative-feedback, anti-inflammatory role for 
intracellular SIgA in response to TLR4 signaling.  Accordingly, induction of pIgR 
expression by a subset of commensal bacteria may be a mechanism by which IECs 
maintain pIgR expression while limiting pro-inflammatory responses in the face of 
continuous interactions with gut bacteria. Consistent with this idea, our lab demonstrated 
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that pIgR expression was selectively upregulated in response to bacteria from the family 
Enterobacteriaceae of the phylum Proteobacteria, suggesting that different types of 
colonic bacteria differentially regulate pIgR expression in IEC.62  
 Similar to results using purified ligands, we demonstrate that induction of the pro-
inflammatory chemokine, IL-8, by EcN in HT-29 cells requires both NF-κB and p38 
MAPK signaling.  Consistent with previous results, the increase in IL-8 was rapid and 
transient, returning to near base-line levels following 24 hours of EcN stimulation. In 
contrast, the slow and sustained induction of pIgR expression by EcN required NF-κB 
signaling, but not MAPK signaling.  In support of these results, our lab has shown that 
EcN induced expression of a negative regulator of MAPK signaling, MKP-1, in HT-29 
cells. Also, we have shown that MKP-1 levels are 16-fold higher in the colon than in the 
small intestine of mice, consistent with the increase bacterial load. Furthermore, these 
levels are significantly reduced in MyD88 deficient mice62.  Accordingly, these results 
suggest that limiting MAPK signaling may be an important role of MyD88-dependent 
TLR signaling by a subset of commensal bacteria. 
Overall, the results presented here demonstrate that IEC utilize distinct 
mechanisms to regulate the expression of the early pro-inflammatory response and the 
late and sustained pIgR response in efforts to maintain intestinal homeostasis.  
Specifically, stimulation of pIgR expression by a subset of commensal bacteria or host 
stimuli would enhance pIgR-mediated transport of protective IgA antibodies, as well as 
innate immune functions mediated by SC.  Transient induction of moderate levels of IL-8 
by IECs, at much lower levels than induced by byproducts of viral replication or other 
non-bacterial stimuli141, would promote influx of neutrophils in sufficient quantities to 
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enhance innate immunity without excess inflammation.  This early pro-inflammatory 
response is rapidly followed by the induction of negative regulatory molecules, such as 
MKP-1, Tollip and Sigirr, that would prevent excess activation of NF-κB and MAPK 
signaling.  Therefore, cross-talk between commensal bacteria and IECs is crucial for 
regulating the levels of NF-κB activity and maintaining of intestinal homeostasis. 
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Figure 4-1 Activation of the classical NF-κB pathway by TNF, LPS, and pIC in 
intestinal epithelial cells. HT-29 cells were stimulated with TNF (10 ng/ml), LPS 
(1mg/ml), or pIC (100mg/ml) for 3 or 24 h, in the presence or absence of 10 mM 
BAY11-7082, an inhibitor of IκBα phosphorylation. Cells cultured in the absence of 
BAY 11-7082 were treated with an equivalent volume of vehicle (DMSO).  mRNA levels 
for IL-8 and pIgR were quantified by quantitative reverse transcriptase- PCR (qRT-PCR) 
and normalized to GAPDH mRNA. Data from three independent experiments were 
combined and expressed as mean ± s.e.m. ( n = 9): a , the mean for stimulated cells is 
significantly greater than the mean for unstimulated cells ( P < 0.05); b, the mean for 
cells treated with BAY 11-7082 is significantly different from the mean for cells given 
the same stimulus in the absence of BAY 11-7082 ( P < 0.05). (Bruno, M.E., Frantz, 
A.L., Rogier, E.W., Johansen, F.E. & Kaetzel, C.S. Regulation of the polymeric 
immunoglobulin receptor by the classical and alternative NF-kappaB pathways in 
intestinal epithelial cells. Mucosal Immunol 4, 468-478(2011)) Reprinted with 
permission. 
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Figure 4-2 Effect of NF-κB inhibition on the response of the LoVo human IEC line 
to LPS, pIC and TNF. LoVo cells were stimulated with TNF (10ng/ml), LPS (1mg/ml) 
or pIC (100 mg/ml) for 3 or 24 h, in the presence or absence of 10 μM BAY 11-7082, an 
inhibitor of IκBα phosphorylation. Cells cultured in the absence of BAY 11-7082 were 
treated with an equivalent volume of vehicle (DMSO). mRNA levels for IL-8 and pIgR 
were quantified by qRT-PCR and normalized to GAPDH mRNA. Data are expressed as 
mean ± SEM (n = 4): a, the mean for stimulated cells is significantly greater than the 
mean for unstimulated cells (p < 0.05); b, the mean for cells treated with BAY 11-7082 is 
significantly different from the mean for cells given the same stimulus in the absence of 
BAY 11-7082 (p < 0.05). (Bruno, M.E., Frantz, A.L., Rogier, E.W., Johansen, F.E. & 
Kaetzel, C.S. Regulation of the polymeric immunoglobulin receptor by the classical and 
alternative NF-kappaB pathways in intestinal epithelial cells. Mucosal Immunol 4, 468-
478(2011)) Reprinted with permission. 
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Figure 4-3 Effect of RelA and RelB knockdown on TNF, LPS, and pIC stimulated 
gene expression. mRNA levels were analyzed by quantitative reverse transcriptase-PCR 
(qRT-PCR) in HT-29 cells stably transfected with control, RelA, or RelB small inhibitory 
RNAs (siRNAs) and treated with TNF (10 ng/ml ), LPS (1 mg/ml), or pIC (100 mg/ml ) 
for 3 or 24 h. Data from two to three independent experiments were combined and 
expressed as mean ± s.e.m. ( n = 8 – 12): a, the mean for stimulated cells is significantly 
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Figure 4-3 (continued) greater than the mean for unstimulated cells expressing the same 
siRNA ( P < 0.05); b , the mean for cells expressing RelA or RelB siRNA is significantly 
different from the mean for cells expressing control siRNA given the same stimulus for 
the same length of time ( P < 0.05). (Bruno, M.E., Frantz, A.L., Rogier, E.W., Johansen, 
F.E. & Kaetzel, C.S. Regulation of the polymeric immunoglobulin receptor by the 
classical and alternative NF-kappaB pathways in intestinal epithelial cells. Mucosal 
Immunol 4, 468-478(2011)) Reprinted with permission. 
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Figure 4-4 Effect of MAPK inhibition on the response of HT-29 cells to tumor 
necrosis factor TNF, LPS, and pIC. HT-29 cells were stimulated with TNF (10 ng/ml), 
LPS (1mg/ml), or pIC (100 mg/ml) for 3 or 24 h, in the presence or absence of individual 
MAPK inhibitors or a combination of the three inhibitors at the same concentrations (10 
mM SB20358, p38 inhibitor; 10 mM SP600125, c-Jun N-terminal kinase (JNK) inhibitor; 
10 mM PD98059, extracellular-regulated kinase (ERK) inhibitor). Cells cultured in the 
absence of MAPK inhibitors were treated with an equivalent volume of vehicle DMSO. 
mRNA levels for IL-8 and pIgR were quantified by quantitative reverse transcriptase-
PCR (qRT-PCR) and normalized to GAPDH mRNA. Data from two independent 
experiments were combined and expressed as mean ± s.e.m.( n = 8): a , the mean for 
stimulated cells is significantly greater than the mean for unstimulated cells ( P < 0.05); 
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Figure 4-4 (continued) b, the mean for cells treated with MAPK inhibitors is 
significantly different from the mean for cells given the same stimulus in the absence of 
MAPK inhibitors ( P < 0.05). (Bruno, M.E., Frantz, A.L., Rogier, E.W., Johansen, F.E. 
& Kaetzel, C.S. Regulation of the polymeric immunoglobulin receptor by the classical 
and alternative NF-kB pathways in intestinal epithelial cells. Mucosal Immunol 4, 468-
478(2011)) Reprinted with permission. 
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 Figure 4-5: Regulation of gene expression by purified ligands for TLR2 and TLR4. 
A. HT-29 cells were cultured for 24 h in the absence or presence of Pam3CSK4 (TLR2 
ligand) or highly purified LPS from E. coli O26:B6 (TLR4 ligand), each at a 
concentration of 1 μg/ml. mRNA levels were quantified by qRT-PCR and normalized to 
GAPDH mRNA. B. HT-29 and THP-1 cells were cultured for 3 h in the absence or 
presence of Pam3CSK4 or LPS, and mRNA levels were analyzed as described for panel 
A. Data from 2 independent experiments were combined and expressed as mean ± SEM 
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Figure 4-5 (continued) (n = 8). Asterisks indicate that the mean is significantly different 
from the corresponding mean for untreated cells from the same cell-line (p < 0.05). 
(Bruno, M.E. et al. Regulation of the polymeric immunoglobulin receptor in intestinal 
epithelial cells by Enterobacteriaceae: implications for mucosal homeostasis. Immunol 
Invest 39, 356-382 (2010)) Reprinted with permission. 
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Figure 4-6 Effect of TLR4 inhibition on the induction of pIgR expression by E. coli 
Nissle. HT-29 cells were stimulated with EcN in the presence or absence of varying 
concentrations of Polymyxin B, an inhibitor of LPS. mRNA levels were quantified by 
qRT-PCR, normalized to b2-M mRNA, and expressed as mean ± SEM (n = 6). Astericks 
indicate that the mean is significantly different for the indicated treatment groups (p 
<0.01); N.S., not significant.  Data from 2 independent experiments were combined and 
expressed as mean ± SEM (n = 8)  
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Figure 4-7. shRNA-mediated knockdown of MyD88 mRNA in a human colon 
carcinoma cell-line HT-29. Clones of HT-29 cells stably transfected with the indicated 
shRNA were stimulated with 106 E coli for 3 and 24 hours. mRNA levels were quantified 
by qRT-PCR, normalized to b2-microglobulin mRNA, and expressed as mean ± SEM (n 
= 6): a, mean for cells treated with E. coli is significantly different from the 
corresponding mean for untreated cells; b, mean for cells expressing MyD88 shRNA is 
significantly different from the mean for cells expressing control siRNA (p < 0.05). 
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Figure 4-8: Effect of NF-κB inhibition on the response of HT-29 cells to E. coli 
Nissle. A. HT-29 cells were stimulated for 3 or 24 h with heat-killed EcN, at a ratio of 10 
bacterial cells per eukaryotic cell, in the presence or absence of 10 μM Bay 11 7082. 
mRNA levels were quantified by qRT PCR and normalized to GAPDH mRNA. Data 
from 3 independent experiments were combined and expressed as mean ± SEM (n = 9): 
a, mean for cells stimulated with EcN is significantly different from the corresponding 
mean for unstimulated cells; b, mean for cells treated with Bay 11-7082 is significantly 
different from the corresponding mean for untreated cells. (Bruno, M.E. et al. Regulation 
of the polymeric immunoglobulin receptor in intestinal epithelial cells by 
Enterobacteriaceae: implications for mucosal homeostasis. Immunol Invest 39, 356-382 
(2010)) Reprinted with permission.  B. HT-29 cells expressing the indicated siRNA were 
stimulated with EcN. mRNA levels were quantified by qRT-PCR, normalized to GAPDH 
mRNA, and expressed as mean ± SEM (n = 4): a, mean for cells treated with EcN is 
significantly different from the mean for untreated cells; b, mean for cells expressing 
RelA or RelB siRNA is significantly different from the mean for cells expressing control 
siRNA (p < 0.05). 
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Figure 4-9: Effect of MAPK inhibition on the response of HT-29 cells to E. coli 
Nissle. HT-29 cells were stimulated with EcN for 3 or 24 h in the presence or absence of 
MAPK inhibitors (PD98059, ERK inhibitor; SB20358, p38 inhibitor; SP600125, JNK 
inhibitor), individually or combined, each at a concentration of 10 μM. mRNA levels 
were quantified by qRT PCR and normalized to GAPDH mRNA. Data from 2 
independent experiments were combined and expressed as mean ± SEM (n = 8): a, mean 
for cells stimulated with EcN is significantly different from the corresponding mean for 
unstimulated cells; b, mean for cells treated with MAPK inhibitors is significantly 
different from the corresponding mean for untreated cells. (Bruno, M.E. et al. Regulation 
of the polymeric immunoglobulin receptor in intestinal epithelial cells by 
Enterobacteriaceae: implications for mucosal homeostasis. Immunol Invest 39, 356-382 
(2010)). Reprinted with permission. 
 Copyright © Aubrey L. Frantz 2012 
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Chapter Five: Targeted deletion of MyD88 in intestinal epithelial cells results in 
compromised antibacterial immunity associated with down-regulation of polymeric 
immunoglobulin receptor, mucin-2 and antibacterial peptides  
 
Introduction 
The mammalian intestine harbors an estimated 100 trillion microorganisms, 
which normally maintain a mutually beneficial relationship with the host.40 The intestinal 
epithelium provides a physical barrier as well as innate immune defense, preventing this 
vast community of microbes from entering host tissues.153  Defects in epithelial barrier 
and immune functions can lead to infections with opportunistic and pathogenic 
microbes154 and contribute to the etiology of inflammatory bowel disease (IBD).155 
Cross-talk between the gut microbiota and intestinal epithelial cells (IECs) is mediated by 
pattern recognition receptors, including the Toll-like receptor (TLR) family,156 leading to 
expression of gene products that enhance epithelial barrier function and innate immunity. 
TLR signaling in the gut is a double-edged sword; whereas physiological TLR signaling 
promotes intestinal homeostasis in healthy individuals, excessive TLR signaling in 
response to invasive microbes can exacerbate intestinal inflammation.24 The cytoplasmic 
adaptor protein MyD88 transduces signals from TLRs that recognize bacterial products.78 
The finding that Myd88-deficient mice exhibited increased susceptibility to chemically-
induced colitis highlighted the importance of physiological TLR signaling for protection 
of the epithelial barrier.157 Studies using bone marrow chimeras of Myd88-deficient and 
wild-type mice in several mouse models of colitis demonstrated that MyD88 signaling in 
hematopoietic cells was required for development of intestinal inflammation, whereas 
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MyD88 signaling in non-hematopoietic cells was required for host survival.158,159  Here 
we used cell type-specific deletion of the Myd88 gene to investigate the role of epithelial-
specific MyD88 signaling in antibacterial immunity and protection against intestinal 
inflammation. 
Secretory immunoglobulin A (SIgA) acts as the first line of antigen-specific 
immunity at the interface between the gut microbiota and the intestinal epithelium.47  
Polymeric IgA secreted by plasma cells in the intestinal lamina propria is transported 
across IECs by the polymeric immunoglobulin receptor (pIgR).160 Importantly, we found 
that reduced expression of pIgR was correlated with greater disease severity in patients 
with IBD60 and in mouse models of experimental colitis.161 Our finding that expression of 
pIgR is regulated in IECs by Toll-like receptor signaling62 suggests that microbial-
epithelial cross-talk is crucial for optimal production of SIgA. Consistent with this 
concept, we found that MyD88-deficient mice had reduced colonic expression of pIgR 
and deficient transport of SIgA.160 However, in that study it was not determined whether 
pIgR was regulated directly by MyD88 signaling in IECs or indirectly by immune cells in 
the intestinal lamina propria. In the present study we used targeted deletion of the Myd88 
gene to demonstrate an essential role for epithelial-specific MyD88 signaling in 
maintaining optimal expression of pIgR and transport of SIgA. 
The thick layer of intestinal mucus acts to separate luminal bacteria from the 
epithelial surface.162 This mucus is rich in antimicrobial peptides163 and associates with 
SIgA via glycan-mediated interactions,164 thus forming an immunological as well as a 
physical barrier against microbial invasion. Here we report that targeted deletion of 
MyD88 in IECs causes down-regulated expression of pIgR, mucin-2 (the major protein 
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constituent of intestinal mucus) and antimicrobial peptides in IECs. We propose a model 
in which MyD88-dependent bacterial-epithelial cross-talk is crucial for maintenance of 
physical and immunological barrier function in the intestine. 
 
Results 
Loss of MyD88 signaling in colonic epithelial cells disturbs the segregation of 
microbiota and host 
To investigate the role of epithelial MyD88 signaling in intestinal homeostasis, 
we generated mice with a targeted deletion of the Myd88 gene in intestinal epithelial cells 
(MyD88∆IEC), by crossing mice carrying loxP-flanked Myd88 alleles (MyD88Flox) with 
mice that express Cre recombinase under the control of the IEC-specific Vil1 
promoter.165 Levels of MyD88 mRNA were significantly reduced in isolated colonic 
epithelial cells (ECs) from MyD88∆IEC mice at 9 weeks of age (Figure 5-1a). 
Immunostaining revealed expression of MyD88 in colonic epithelial cells (ECs) and 
lamina propria mononuclear cells (LPMCs) of MyD88Flox mice, whereas MyD88∆IEC 
mice lacked MyD88 expression in ECs but retained expression in LPMCs (Figure 5-1b). 
Compared to MyD88Flox littermates, MyD88∆IEC mice showed no histological signs of 
intestinal inflammation at 9 weeks of age (Figure 5-1b), or when followed up to 12 
months (Figure 5-2). No pathological changes in colon morphology were observed. 
Although there were no differences in numbers of culturable bacteria in feces from 
MyD88Flox and MyD88∆IEC mice, we observed increased mucus-associated CFU in 
MyD88∆IEC mice (Figure 5-1c). These differences were not restricted to culturable 
bacteria, since similar trends where observed when using qRT-PCR of 16s rDNA to 
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quantify bacterial numbers (Figure 5-3). Furthermore, increased bacterial attachment to 
the epithelial surface in MyD88∆IEC mice was correlated with increased translocation of 
bacteria to the draining mesenteric lymph nodes (MLNs) (Figure 5-1d, e). Interestingly, 
about 25% of bacterial colonies cultured from MLNs of MyD88∆IEC mice had a large, 
mucoid morphology and were identified as Klebsiella pneumoniae by sequencing of 16S 
rRNA genes and biochemical tests (Figure 5-4). No bacteria could be cultured from the 
spleens of MyD88∆IEC mice, suggesting that infection with gut-derived bacteria was 
confined to the mucosal immune system. These findings indicate that epithelial-specific 
MyD88 signaling is required for normal segregation of gut commensals from host tissues.  
 
Loss of MyD88 signaling in colonic epithelial cells compromises epithelial barrier 
function 
We hypothesized that increased epithelial permeability in MyD88∆IEC mice, 
coupled with increased numbers of mucus-adherent bacteria, could result in leakage of 
bacteria into the lamina propria and travel via the lymphatics to MLNs.  Measurement of 
transmucosal electrical resistance (TER) in isolated colonic tissues revealed significant 
decreases in MyD88∆IEC mice, indicative of decreased epithelial barrier function (Figure 
5-5a). This ex vivo analysis was supported by the in vivo observation of elevated levels of 
serum albumin in the feces of MyD88∆IEC mice, reflecting leakage of serum proteins into 
the intestinal lumen (Figure 5-6). To determine whether increased mucosal adherence 
and epithelial translocation of bacteria in MyD88∆IEC mice was selective for opportunistic 
pathogens such as K. pneumoniae, we treated mice orally for 7 days with an 
environmental, nonpathogenic strain of E. coli (Nissle 1917),166 which had been 
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transformed to kanamycin resistance. We observed similar numbers of KanR E. coli in 
feces and luminal washes from MyD88Flox and MyD88∆IEC mice, but significantly 
increased numbers in the colonic mucus of MyD88∆IEC mice (Figure 5-5b), consistent 
with the finding that mucus extracted from MyD88∆IEC mice had reduced antibacterial 
activity compared to MyD88Flox mice (Figure 5-5c). However, these KanR E. coli did not 
translocate to the MLNs of MyD88∆IEC mice (data not shown). These results suggested 
that increased mucosal adherence of bacteria in MyD88∆IEC mice may be non-selective, 
whereas translocation to the draining lymph nodes may be selective for more aggressive 
bacteria such as K. pneumoniae. 
We hypothesized that loss of epithelial MyD88 signaling could result in increased 
bacterial invasion of IECs.  To assess epithelial invasion independent of the confounding 
effects of local immune cells, we performed in vitro bacterial invasion assays in the 
human HT-29 colon carcinoma cell-line. We tested the effects of shRNA-mediated 
knockdown of MyD88 (Figure 4-7 for shRNA knockdown of MyD88) on attachment 
and invasion of three species of Gram-negative bacteria of the family 
Enterobacteriaceae: the non-invasive E. coli strain Nissle 1917, the opportunistic 
pathogen K. pneumoniae (a strain isolated from the MLN of a MyD88∆IEC mouse), and 
the invasive pathogen Salmonella typhimurium (strain SL1344) (Figure 5-5d). 
Knockdown of MyD88 expression in HT-29 cells resulted in significantly increased 
adherence of all 3 bacterial species to the epithelial surface. As expected, the magnitude 
of epithelial invasion by E. coli and K. pneumoniae was dramatically lower than was 
observed for S. typhimurium, but invasion of all 3 species was significantly increased 
when expression of MyD88 was reduced. Taken together, our findings suggest that 
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MyD88 signaling in ECs plays a crucial role in intestinal immunity by increasing 
antibacterial activity of epithelial mucus, reducing bacterial adherence to the epithelial 
surface, maintaining epithelial barrier function, and preventing bacterial invasion of 
epithelial cells.  
 
Loss of MyD88 signaling in intestinal epithelial cells alters the composition of the 
gut microbiota  
We hypothesized that compromised innate immunity resulting from loss of 
epithelial MyD88 signaling would affect the balance of the gut bacterial community, 
resulting in an altered composition of the gut microbiota in MyD88∆IEC mice. The 
richness and diversity of fecal bacteria was analyzed by the PhyloChipTM assay, a 
microarray-based method that measures the relative abundance of more than 59,000 
individual microbial taxa in fecal DNA by analysis of the entire 16S ribosomal RNA 
gene sequence,108 in MyD88Flox and MyD88∆IEC mice. While the overall richness of the 
fecal microbiota of MyD88Flox and MyD88∆IEC mice was similar (Figures 5-7 and 5-8), 
significant differences were observed in the relative abundance of operational taxonomic 
units (OTUs, defined as a group of highly similar 16S rRNA gene sequences, in most 
cases with similarity > 99%) within several bacterial families (Figure 5-9). A large 
proportion of families in the phylum Bacteroidetes were decreased in abundance in 
MyD88∆IEC mice, whereas a large proportion of families in the phylum Proteobacteria 
were increased. Within the phylum Firmicutes, the abundance of some families were 
increased while others were decreased in MyD88∆IEC mice. Principal component analysis 
(PCA), which was used to visualize complex relationships among multiple bacterial 
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families in individual mice, revealed significant differences between MyD88Flox and 
MyD88∆IEC mice (Figure 5-10a, left panel). Interestingly, the composition of the 
microbiota was much more variable among individual MyD88Flox mice than among 
individual MyD88∆IEC mice, as indicated by the tight clustering of the five MyD88∆IEC 
mice in the 2-dimensional PCA plot. This result suggests that loss of epithelial MyD88 
signaling may cause specific and reproducible changes in the bacterial community, 
consistent with the finding that the abundance of 2647 OTUs differed significantly 
between MyD88Flox and MyD88∆IEC mice (Figure 5-10a, right panel). The Prediction 
Analysis for Microarrays (PAM) method111 was used to identify “distinctive” OTUs 
whose relative abundance characterizes the unique microbiota of MyD88Flox and 
MyD88∆IEC mice (Figure 5-10b). This analysis identified 4 distinctive OTUs in the TM7 
candidate division that were characteristic of MyD88∆IEC mice, and 7 OTUs within the 
genus Lactobacillus (phylum Firmicutes) that were characteristic of MyD88Flox mice. 
Interestingly, the relative abundance of five bacterial species that have been associated 
with altered innate and adaptive immunity in the gut, including Candidatus arthromitus 
(SFB),167 Escherichia coli,77 Pseudomonas fluorescens, 77 Klebsiella pneumonia168 and 
Proteus mirabilis,168 did not differ significantly in the fecal microbiota of MyD88Flox and 
MyD88∆IEC mice (Figure 5-10c). This finding suggests that translocation of K. 
pneumoniae to the MLNs of MyD88∆IEC mice (Figure 5-1e) was due to a specific defect 
in the host response to this bacterium, and not simply to an increase in the abundance of 
K. pneumoniae in the gut microbiota. 
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Loss of MyD88 signaling in intestinal epithelial cells results in altered epithelial gene 
expression and reduced transcytosis of IgA 
To determine whether loss of epithelial MyD88 signaling resulted in altered 
patterns of gene expression, we isolated colonic epithelial cells from MyD88Flox and 
MyD88∆IEC mice and analyzed mRNA levels. 36 genes were chosen for mRNA analysis 
based on our previous studies and other reports implicating these genes as targets of 
MyD88 signaling, or having roles in epithelial cell function, innate immune signaling 
and/or colonic inflammation (Table 5-2).  These genes included: 5 signature biomarkers 
that we have shown to be correlated with disease severity in human IBD and mouse 
models of colitis (Pigr, Rela, Tnfaip3, Tnf, Cxcl2)161; Relb, which encodes the RELB 
subunit of the alternative NF-κB signaling pathway, which we have shown to be 
implicated in regulation of Pigr gene transcription105;Muc2, which encodes the major 
colonic mucin protein, the loss of which is associated with spontaneous development of 
colitis37; genes associated with epithelial homeostasis and barrier function (Areg158, 
Bcl2l1169, Birc2170, Mmp3 and Mmp9171, Tcf4172, Mylk71 and Tjp1173); antimicrobial 
peptides (Defa6163, Defa-rs1 [FE Johansen, personal communication], Reg3g42, Tff3174 ); 
genes involved in MyD88-dependent TLR signaling and protection against experimental 
colitis (Myd88159,Tlr2175, Tlr4176, Tlr580); genes involved in intracellular immune 
signaling (Smad7177, Stat3178); and a number of pro- and anti-inflammatory cytokines, 
chemokines and biological mediators that have been implicated in protection against or 
exacerbation of colitis (Ccl2179, Cxcl1179, Il10180, Il13181, Il18182, Il1b183, Il6157, Ptgs2184, 
Tgfb1177, Tnfs13b45, Tslp185).  Among these genes, five (including MyD88, as a positive 
control) were down-regulated in MyD88∆IEC mice, and none were up-regulated (Figure 
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5-11a). The most significantly down-regulated gene was the polymeric immunoglobulin 
receptor (Pigr), the epithelial transporter for polymeric IgA antibodies. Immunostaining 
of colon tissues revealed that expression of pIgR and co-localization with IgA were 
severely down-regulated in epithelial cells of MyD88∆IEC mice (Figure 5-11b), and fecal 
levels of IgA levels were significantly reduced (Figure 5-11c). Importantly, this 
reduction in luminal IgA was similar to the reduction we previously reported in MyD88-/- 
mice11, supporting a direct role for epithelial MyD88 signaling in regulating IgA 
transcytosis.  Consistent with these results, we confirmed a direct role for epithelial 
MyD88 signaling in regulating pIgR expression by demonstrating that shRNA-mediated 
knockdown of MyD88 expression in the human HT-29 colon carcinoma cell-line 
significantly reduced the up-regulation of pIgR in response to bacterial stimulation 
(Chapter 4, Figure 4-7). Other down-regulated genes included mucin-2 (Muc2), the 
major protein constituent of intestinal mucus, and the antimicrobial peptides regenerating 
islet-derived IIIγ (Reg3g) and defensin-α related sequence 1 (Defa-rs1). Although there 
were no significant differences in goblet cell numbers in the colonic epithelia of 
MyD88Flox and MyD88∆IEC mice (Figure 5-12), immunostaining revealed that the level 
of mucin-2 protein per goblet cell was reduced in MyD88∆IEC mice (Figure 5-11d). 
Down-regulation of RegIIIγ and Defa-rs1likely contributed to the reduced antimicrobial 
activity of colonic mucus in MyD88∆IEC mice (Figure 5-5c). Interestingly, we found that 
expression of many epithelial genes that have been previously been reported to be 
regulated by MyD88 signaling, including Areg, IL-6, TLR4,and Ptgs2, was not altered in 
MyD88∆IEC mice. It is possible that MyD88-dependent signaling from other cell types 
may supply cues that regulate expression of these genes.  
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Loss of MyD88 signaling in colonic epithelial cells results in increased susceptibility 
to dextran sulfate sodium-induced colitis 
 Inappropriate inflammatory responses to normal components of the intestinal 
microbiota are thought to play a major role in the pathogenesis of IBD.79,155,186 Although 
we observed no overt inflammatory disease in MyD88∆IEC mice, they exhibited several 
defects that have been reported in IBD patients, including reduced expression of pIgR,60 
MUC2,187 and antimicrobial peptides163,188 as well as perturbed spatial relationships 
between microbiota and host.42,69 To test the hypothesis that MyD88∆IEC mice are more 
susceptible to experimental colitis, acute epithelial damage was induced by 
administration of 2% dextran sulfate sodium (DSS) in the drinking water for 7 days. 
MyD88∆IEC mice had significantly higher disease activity than did MyD88Flox mice, 
beginning as early 1 day after initiation of DSS treatment (Figure 5-13a). At the 
termination of the experiment, increased inflammatory cell infiltration and epithelial 
destruction were observed in colons of MyD88∆IEC mice (Figure 5-13b,c). Surprisingly, 
we did not detect expression of several genes that have previously been reported to be 
produced by intestinal epithelial cells (Defa-6, Tnfsf13b, Il-13, Il-10, Tslp) in epithelial 
cells from either MyD88∆IEC or MyD88Flox mice under normal or inflammatory 
conditions (Table 5-2).  Nineteen genes from a total of 36 were selected for principal 
component analysis (PCA), based on ranking of P values for the comparison of mRNA 
transcript levels in MyD88∆IEC and  MyD88Flox mice, with and without DSS treatment (n 
= 31) (Tables 5-2, 5-3 and 5-4). Factor analysis by the principal component method3 
detected a significant relationship among the 19 transcripts (Χ2 = 816.7, p < 0.0001), and 
reduced the data to 4 principal components (PCs) (Figure 5-14).  PC1 and PC2 together 
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accounted for 68.8% of the overall variance in gene expression, whereas PC3 and PC4 
only contributed minimally (variance proportion < 0.1). Scores for PC1 and PC2 for each 
individual mouse were calculated as the sum of normalized expression levels for each 
gene multiplied by the corresponding coefficient for PC1 and PC2. This principal 
component analysis of gene expression in colonic ECs following DSS treatment revealed 
significantly different patterns in MyD88∆IEC and MyD88Flox mice (Figure 5-13d) 
Expression of 10 genes was significantly down-regulated and expression of 5 genes was 
up-regulated in colonic ECs from MyD88Flox mice following DSS treatment (Figure 5-
13e, top panel). Interestingly, MyD88∆IEC mice were defective in their ability to up-
regulate the expression of the pro-inflammatory factors TNF, CXCL2 and IL-1β in 
colonic ECs in response to DSS-induced damage (Figure 5-13e, bottom panel). Aberrant 
up-regulation of the antimicrobial peptide Defa-rs1 in colonic ECs of MyD88∆IEC mice 
may have been caused by increased microbial stimulation secondary to increased 
epithelial damage in these mice. These findings suggest that lack of epithelial MyD88 
expression causes specific defects in innate immune gene expression, resulting in a 
compromised host response to epithelial injury and increased colonic inflammation.  
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D
Protection against bacterial invasion and infection in the intestine is dependent on 
the resident microbiota, the mucus layer containing SIgA and antimicrobial peptides, and 
the monolayer of IECs that provide a physical and innate immune barrier154.  Here we 
demonstrated that loss of epithelial MyD88 signaling compromises antibacterial 
immunity at all three layers of defense, resulting in translocation of bacteria to mesenteric 
lymph nodes. Loss of MyD88 in IECs did not cause spontaneous colitis, but rendered 
mice more susceptible to inflammation caused by the epithelial damaging agent DSS. 
These findings demonstrate the critical role of epithelial MyD88 signaling in 
maintenance of intestinal barrier function and protection against inflammation.  
Unlike the inflammatory response generated by MyD88-dependent TLR signaling 
in immune cells, IECs respond by producing factors involved in epithelial cell 
proliferation, maintenance of barrier function, innate antimicrobial immunity and 
transport of SIgA.160,6 Here we report that targeted deletion of the Myd88 gene in IECs 
was associated with reduced expression of pIgR and epithelial transport of IgA, providing 
direct evidence for the first time that epithelial MyD88 signaling regulates the production 
of SIgA. These SIgA antibodies in turn modulate the composition of the gut microbiota 
and form the first line of antigen-specific immunity that prevents invasion of IECs by 
members of the gut microbiota.45 This connection between epithelial MyD88 signaling, 
SIgA production and host-microbial homeostasis provides a potential explanation for our 
previous findings that reduced pIgR expression and SIgA transport were correlated with 
disease severity in human inflammatory bowel disease60 and in mouse models of 
experimental colitis.161 We previously reported189 that expression of pIgR was up-
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regulated by TNF and IL-1β, the latter of which signals through a MyD88-dependent 
pathway. 190 We found here that loss of epithelial MyD88 signaling was associated with 
defective production of IL-1β and TNF in colonic ECs in response to DSS-induced 
inflammation, suggesting that MyD88 may coordinate the response of IECs to autocrine 
and paracrine stimulation with IL-1 and TNF, as well as TLR signaling.  
The intestinal epithelium is protected by a mucus layer that increases in thickness 
from the small to the large bowel in proportion to the density of the microbiota.36 In 
addition to its role as a physical barrier, mucus serves to trap protective factors such as 
SIgA and antimicrobial peptides.154, 191 We found that colonic ECs from MyD88∆IEC mice 
produced significantly less Muc-2, antimicrobial peptides RegIIIγ and Defa-rs1, and 
SIgA, consistent with reduced antimicrobial activity in colonic mucus. Vaishnava et al.42 
recently reported that mice with a targeted deletion of MyD88 in IECs had reduced 
expression of the antimicrobial peptide RegIII-γ in the terminal ileum, and increased 
bacterial colonization of small intestinal surfaces. Gong et al.81 reported that mice 
transgenic for an IEC-targeted, dominant-negative mutant of MyD88 had reduced 
expression of antimicrobial peptides in the small intestine and increased bacterial 
translocation to MLNs. MyD88 signaling may also provide cues to immune cells for 
regulating the expression of antimicrobial and innate immune factors. Ismail et al.192 
found that expression of RegIII-γ in small intestinal γδ intraepithelial lymphocytes (IELs) 
was dependent on epithelial-specific MyD88 signaling, but not on expression of MyD88 
within the IELs themselves. Thus epithelial MyD88 signaling provides direct and indirect 
signals to augment production of antimicrobial factors that segregate the microbiota from 
host tissues. 
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  In our studies, a hallmark of epithelial-specific MyD88 deficiency was 
translocation of bacteria to the draining MLNs, including the opportunistic pathogen 
Klebsiella pneumoniae. This Gram-negative bacterium of the family Enterobacteriaceae 
is commonly found among the resident gut bacteria in both humans and mice, but has 
limited invasive potential in healthy individuals.193 Although the defect in epithelial 
barrier function in MyD88∆IEC mice may have contributed to paracellular leakage of 
bacteria into the lamina propria, we did not observe translocation of commensal E. coli 
to the MLNs of MyD88∆IEC mice, even though these bacteria colonized the mucus layer 
of the colon. We conclude that virulence factors expressed by K. pneumoniae, but not by 
commensal E. coli, may be required for survival during transit from the mucosal surface 
to the MLNs. In contrast, Fukata et al.77 reported translocation of E. coli to the MLNs in 
mice deficient in MyD88 in all cell types. MyD88-deficient mice have been shown to be 
highly susceptible to systemic infections with a broad range of bacteria.194 Intratracheal 
infection of MyD88-deficient mice with K. pneumoniae resulted in severe pneumonia, 
attenuated neutrophil influx, and systemic dissemination of bacteria.195 Rare cases of 
autosomal recessive MyD88 deficiency in humans were found to be associated with 
recurrent life-threatening infections with pyogenic bacteria early in life,194 including an 
acute urinary tract infection caused by K. pneumoniae in a 4 month-old boy. However, 
we did not observe systemic bacterial infections in MyD88∆IEC mice. We conclude that 
epithelial MyD88 signaling is required for preventing the translocation of K. pneumoniae 
and possibly other opportunistic pathogens to the MLNs, but that MyD88-sufficient 
immune cells can prevent the systemic spread of resident gut bacteria that have 
penetrated the mucosal barrier.  
111 
 
Our findings have revealed for the first time a unique role for epithelial MyD88 
signaling in shaping the composition of the resident gut microbiota, including increased 
numbers of OTUs in the phylum Proteobacteria and decreased numbers of OTUs within 
the phylum Bacteroidetes in MyD88∆IEC mice. Interestingly, similar changes in the 
composition of the gut microbiota have been observed in human IBD patients.196 Altered 
host factors that are believed to impact commensal bacteria in IBD patients include 
increased intestinal permeability, decreased production of antimicrobial peptides and 
aberrant SIgA responses,196 all of which characterize the immune defects in mice with a 
targeted deletion of MyD88 in IECs. In addition to changes at the level of bacterial phyla 
and families, the Prediction Analysis for Microarrays technique identified 4 “signature” 
OTUs in the candidate division TM7, whose increased abundance was characteristic of 
the altered microbiota of MyD88∆IEC mice. Importantly, increased abundance of TM7 
bacteria have been reported in humans with oral inflammation197  and IBD.198  Increased 
abundance of TM7 bacteria has been reported in the gut microbiota of mice deficient in 
the NLRP6 inflammasome, accompanied by the development of spontaneous intestinal 
inflammation and increased susceptibility to DSS-induced colitis.182 Reduced production 
of IL-18, which transduces signals through MyD88, was characteristic of NLRP6-
deficient mice. Thus impaired MyD88 signaling in the intestine may alter the local 
microenvironment to favor expansion of TM7. In contrast, we did not observe changes in 
the gut microbiota of MyD88∆IEC mice that have been associated with other mouse 
models of intestinal inflammation caused by defects in immune cells, such as increased 
abundance of Gram-positive segmented filamentous bacteria (Candidatus arthromitus), 
which have been implicated in the expansion of Th17 cells and inflammation of the gut 
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and extraintestinal tissues167. Neither did we observe expansion of Proteus mirabilis nor 
Klebsiella pneumoniae, two Gram-negative species of the family Enterobacteriaceae, the 
abundance of which was increased in the gut microbiota of mice with defective immunity 
in dendritic cells in the intestinal lamina propria.168 Increased colonization with 
Enterobacteriaceae and elevated titers of Enterobacteriaceal antibodies have been 
associated with IBD in humans,199 and species of the genus Klebsiella are observed more 
frequently in the stool of ulcerative colitis patients than healthy controls.200 Our finding 
of unique changes in the gut microbiota of MyD88∆IEC mice suggests that epithelial 
MyD88 signaling is required to protect against abnormal expansion of specific members 
of the gut microbial community. 
Although loss of epithelial MyD88 signaling was not sufficient to cause 
spontaneous intestinal inflammation for at least one year of life, it was associated with 
increased severity of colitis following oral administration of the epithelial damaging 
agent, DSS. A potential mechanism for the increased susceptibility to DSS-induced 
colitis was suggested by our observation that MyD88∆IEC mice failed to up-regulate 
expression of TNF, CXCL2 and IL-1β in colonic ECs in response to epithelial damage. 
This finding was somewhat surprising, considering that these factors are generally 
considered to be pro-inflammatory and their increased expression has been linked to 
increased disease severity in experimental colitis.157 Our data are consistent with the 
notion that “physiological” inflammatory responses by IECs are a normal response to the 
continuous presence of the gut microbiota, and are necessary for repair of damaged 
epithelial cells. On the other hand, massive infiltration of gut microbes into the intestinal 
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DISCUSSION 
Protection against bacterial invasion and infection in the intestine is dependent on 
the resident microbiota, the mucus layer containing SIgA and antimicrobial peptides, and 
the monolayer of IECs that provide a physical and innate immune barrier154.  Here we 
demonstrated that loss of epithelial MyD88 signaling compromises antibacterial 
immunity at all three layers of defense, resulting in translocation of bacteria to mesenteric 
lymph nodes. Loss of MyD88 in IECs did not cause spontaneous colitis, but rendered 
mice more susceptible to inflammation caused by the epithelial damaging agent DSS. 
These findings demonstrate the critical role of epithelial MyD88 signaling in 
maintenance of intestinal barrier function and protection against inflammation.  
Unlike the inflammatory response generated by MyD88-dependent TLR signaling 
in immune cells, IECs respond by producing factors involved in epithelial cell 
proliferation, maintenance of barrier function, innate antimicrobial immunity and 
transport of SIgA.160,6 Here we report that targeted deletion of the Myd88 gene in IECs 
was associated with reduced expression of pIgR and epithelial transport of IgA, providing 
direct evidence for the first time that epithelial MyD88 signaling regulates the production 
of SIgA. These SIgA antibodies in turn modulate the composition of the gut microbiota 
and form the first line of antigen-specific immunity that prevents invasion of IECs by 
members of the gut microbiota.45 This connection between epithelial MyD88 signaling, 
SIgA production and host-microbial homeostasis provides a potential explanation for our 
previous findings that reduced pIgR expression and SIgA transport were correlated with 
disease severity in human inflammatory bowel disease60 and in mouse models of 
experimental colitis.161 We previously reported189 that expression of pIgR was up-
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Figure 5-1 Targeted deletion of MyD88 in intestinal epithelial cells results in 
increased numbers of mucus-associated bacteria and bacterial translocation to 
mesenteric lymph nodes. (a) Mice with a targeted deletion of the Myd88 gene in 
intestinal epithelial cells (IEC) (MyD88IEC) were created by crossing mice in which both 
copies of the MyD88 gene were flanked with loxP sites (MyD88Flox) with mice 
expressing Cre recombinase under the control of the IEC-specific Vil1 promoter.                    
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Figure 5-1 (continued) Levels of MyD88 mRNA were analyzed in colonic epithelial 
cells isolated from 9 week-old littermate MyD88Flox and MyD88IEC mice by Nanostring 
nCounterTM hybridization. mRNA transcript abundance was normalized as described in 
Materials and Methods, and expressed as mean ± SEM (n=15). (b) Colon tissue sections 
from MyD88Flox and MyD88IEC mice were stained with hematoxylin and eosin (upper 
panels) or FITC-labeled antibodies to MyD88 (green) and the nuclear stain DAPI (blue) 
(lower panels). (c) Bacterial colony-forming units (CFU) were enumerated following 
anaerobic culture of fecal homogenates (CFU/g feces), luminal washes (CFU/ml PBS), 
and surface mucus (CFU/100l mucus) from colons of MyD88Flox and MyD88IEC mice. 
Data are expressed as mean ± SEM (n = 6). (d) Bacterial colonies cultured under 
anaerobic conditions from mesenteric lymph nodes (MLNs) of representative MyD88Flox 
and MyD88IEC mice. Large mucoid colonies from MyD88IEC mice were identified as 
Klebsiella pneumoniae by sequence analysis of 16S rRNA genes and biochemical tests 
(Figure 5-3). (e) CFU of total anaerobic bacteria and K. pneumoniae cultured from 
MLNs of MyD88Flox and MyD88IEC mice. Data in the bar graph are expressed as CFU 
per MLN (mean ± SEM, n = 27). The numbers below the bar graph indicate the 
percentage of mice of each genotype from which bacteria (total and K. pneumoniae) 
could be cultured from MLNs. In all panels, asterisks indicate that the mean for 
MyD88IEC mice is significantly different from the mean for MyD88Flox mice (p < 0.05).  
(Frantz et al. Targeted deletion of MyD88 in intestinal epithelial cells results in 
compromised antibacterial immunity associated with the down-regulation of polymeric 
immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal Immunology,in 
press 2012) Reprinted with permission. 
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Figure 5-2 MyD88∆IEC mice do not develop spontaneous colitis with age. Colon 
histology from representative mice at 6, 9 and 12 months of age. Images of formalin-
fixed colon tissues stained with hematoxylin and eosin were captured with a 20X 
objective.  (Frantz et al. Targeted deletion of MyD88 in intestinal epithelial cells results 
in compromised antibacterial immunity associated with the down-regulation of polymeric 
immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal Immunology,in 
press 2012) Reprinted with permission 
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Figure 5-3. Quantification of bacteria in colonic niches of MyD88Flox and MyD88∆IEC 
mice. Bacterial 16sRNA was quantified by qRT-PCR from fecal homogenates (CFU/g 
feces), luminal washes (CFU/ml PBS), and surface mucus (CFU/100 ml mucus) from 
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Figure 5-3 (continued) MyD88Flox and MyD88IEC mice. Data are expressed as mean ± 
SEM (n = 5). (Frantz et al. Targeted deletion of MyD88 in intestinal epithelial cells 
results in compromised antibacterial immunity associated with the down-regulation of 
polymeric immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal 
Immunology,in press 2012) Reprinted with permission. 
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Figure 5-4 Identification of Klebsiella pneumoniae in the mesenteric lymph nodes 
(MLN) of MyD88∆IEC mice. (a) Sequence of the 16S rRNA gene amplified from mucoid 
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Figure 5-4 (continued) bacterial colonies isolated from MLNs of MyD88IEC mice. 
Identical sequences were obtained from colonies isolated from 2 different MyD88IEC 
mice. (b) BLAST alignments of the unknown 16S rRNA sequence with known bacterial 
genome sequences in the National Center for Biotechnology Information database. 
Alignments are shown for 5 Klebsiella pneumoniae strains and 3 Escherichia coli strains 
with at least 98% query coverage, ranked by maximum alignment score.  (c) Biochemical 
tests used to differentiate Klebsiella pneumonia from other Klebsiella species and 
Escherichia coli.  Two different clones isolated from MLNs of different MyD88IEC mice 
and Escherichia coli strain Nissle1917 were tested and compared to expected results. 
(Frantz et al. Targeted deletion of MyD88 in intestinal epithelial cells results in 
compromised antibacterial immunity associated with the down-regulation of polymeric 
immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal Immunology,in 
press 2012) Reprinted with permission. 
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Figure 5-5 Loss of MyD88 expression in intestinal epithelial cells compromises 
epithelial barrier integrity. (a) Epithelial barrier function. Transmucosal electrical 
resistance (TER) was analyzed ex vivo in isolated mouse colon tissues placed in Ussing 
chambers. Data are expressed as a mean ± SEM (n = 8). (b) Association of exogenous, 
noninvasive bacteria with colonic mucus. MyD88Flox and MyD88∆IEC mice were 
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Figure 5-5 (continued) administered E. coli strain Nissle 1917 that had been transformed 
to kanamycin resistance (KanR E. coli) at a dose of 2.5 x 107 CFU/ml in the drinking 
water for 7 days. Kanamycin-resistant colonies were enumerated after anaerobic culture 
of fecal homogenates (CFU/g feces), luminal washes (CFU/ml PBS), and epithelial-
associated mucus (CFU/100l mucus). Data are expressed as mean ± SEM (n= 6). 
(c) Antibacterial activity of colonic mucus. Aliquots of mucus harvested from the colons 
of MyD88Flox and MyD88IEC mice were incubated for 15 min with 106 CFU of KanR E. 
coli, then cultured in the presence of kanamycin to enumerate surviving E. coli. Data are 
expressed as mean ± SEM (n = 6). (d) In vitro bacterial invasion assays. Clones of the 
HT-29 human colon carcinoma cell-line were stably transfected with shRNA specific for 
MyD88 or a random control sequence. Cell monolayers (2 cm2) were incubated with 106 
CFU (MOI of 10:1) of E. coli strain Nissle 1917, a strain of K. pneumoniae isolated from 
MLNs of MyD88IEC mice, or Salmonella typhimurium strain SL1344. Membrane-bound 
CFU were enumerated by anaerobic culture of cell homogenates after washing to remove 
unbound bacteria, and intracellular CFU were enumerated in parallel plates after 2 hours 
of treatment of cell monolayers with gentamicin to kill all extracellular bacteria. Data are 
expressed as mean ± SEM (n = 6). Asterisks indicate that the mean for MyD88IEC mice 
is significantly different from the mean for MyD88Flox mice (panels a-c) or that the mean 
for cells expressing MyD88 shRNA is significantly different from the mean for cells 
expressing control shRNA (panel d) (p < 0.05). (Frantz et al. Targeted deletion of 
MyD88 in intestinal epithelial cells results in compromised antibacterial immunity 
associated with the down-regulation of polymeric immunoglobulin receptor, mucin-2 and 
antibacterial peptides. Mucosal Immunology,in press 2012) Reprinted with permission. 
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Figure 5-6 Fecal Albumin levels in MyD88∆IEC. Feces were collected from 10 week old 
MyD88Flox and MyD88∆IEC mice and serum albumin levels were determined by ELISA. 
Data are expressed as mean ± SEM (n = 5). (Frantz et al. Targeted deletion of MyD88 in 
intestinal epithelial cells results in compromised antibacterial immunity associated with 
the down-regulation of polymeric immunoglobulin receptor, mucin-2 and antibacterial 
peptides. Mucosal Immunology,in press 2012) Reprinted with permission. 
  
126 
 
 
Figure 5-7 Archaeal (green) and bacterial (blue) subfamily richness in individual 
MyD88Flox and MyD88∆IEC mice.  Each bar represents an individual mouse. The Y axes 
indicate the number of distinct bacterial or archaeal subfamilies indentified in fecal DNA 
from each mouse, based on taxonomic classification of 16S rRNA sequences.  (Frantz et 
al. Targeted deletion of MyD88 in intestinal epithelial cells results in compromised 
antibacterial immunity associated with the down-regulation of polymeric 
immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal Immunology,in 
press 2012) Reprinted with permission.  
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Figure 5-8 Proportions of operational taxonomic units (OTUs) classified at the 
family rank in fecal DNA from MyD88∆IEC and  MyD88Flox mice. Each bar represents 
an individual mouse. The size of each color block represents the number of detected 
OTUs in that family relative to the total number of OTUs detected in fecal DNA from 
that mouse. (Frantz et al. Targeted deletion of MyD88 in intestinal epithelial cells results 
in compromised antibacterial immunity associated with the down-regulation of polymeric 
immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal Immunology,in 
press 2012) Reprinted with permission. 
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 Figure 5-9 Differences in the composition of the fecal microbiota of MyD88Flox and 
MyD88∆IEC mice. The relative abundance of operational taxonomic units (OTUs) was 
quantified by PhylochipTM microarray analysis of 16S rRNA gene sequences in fecal 
DNA from 4 MyD88Flox and 5 MyD88∆IEC littermate mice (see Methods for details of 
data analysis). A representative 16S rRNA gene from each of 109 differentially expressed 
OTUs was aligned and used to infer the phylogenetic tree shown in this figure. The rings 
around the tree comprise a heatmap where the inner ring includes the samples from 
MyD88Flox mice, and the outer ring includes the samples from MyD88∆IEC mice. Blue 
lines indicate that the OTU was more abundant in that sample than in the mean of 
MyD88Flox mice samples, and red lines indicate that the OTU was less abundant. The 
color saturation indicates the fold difference in OTU abundance for each mouse 
compared to the mean for MyD88Flox mice. (Frantz et al. Targeted deletion of MyD88 in 
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Figure 5-9 (continued) intestinal epithelial cells results in compromised antibacterial 
immunity associated with the down-regulation of polymeric immunoglobulin receptor, 
mucin-2 and antibacterial peptides. Mucosal Immunology,in press 2012) Reprinted with 
permission. 
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Figure 5-10 Loss of MyD88 expression in intestinal epithelial cells is associated with 
changes in the composition of the fecal microbiota. (a) Principal component analysis 
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Figure 5-10 (continued) (PCA) was used to generate two-dimensional ordination plots 
that visualize complex relationships between the fecal microbiota of individual 
MyD88Flox and MyD88IEC mice, based on weighted Unifrac distances between OTUs 
detected in fecal samples. The graph on the left is based on 14193 OTUs present in at 
least one mouse, and the graph on the right is based on 2647 OTUs with significant 
differences in abundance between MyD88Flox and MyD88IEC mice. (c) Significant OTUs 
that characterize the distinctive microbiota of MyD88Flox and MyD88IEC mice were 
identified using the Prediction Analysis for Microarrays (PAM) method. Data in the bar 
graph are expressed as fold difference (log2, mean ± SEM) in abundance between 
MyD88IEC (n = 5) and MyD88Flox mice (n = 4). Bars to the right of the zero line 
represent distinctive OTUs that were more abundant in MyD88IEC mice, all of which 
were classified in the candidate phylum TM7. Bars to the left represent distinctive OTUs 
that were more abundant in MyD88Flox mice, all of which were classified in the genus 
Lactobacillus (phylum Firmicutes). Numbers in parentheses on the Y-axis are the IDs for 
individual OTUs (see Table 5-1 for complete taxonomy of the distinctive OTUs). (d) 
Relative abundance of 5 species of fecal bacteria in individual MyD88Flox and MyD88IEC 
mice. Because each of these species (except Candidatus arthromitus) comprised multiple 
OTUs, the OTU which represented the biggest difference in abundance between 
MyD88Flox and MyD88IEC mice is displayed. (Frantz et al. Targeted deletion of MyD88 
in intestinal epithelial cells results in compromised antibacterial immunity associated 
with the down-regulation of polymeric immunoglobulin receptor, mucin-2 and 
antibacterial peptides. Mucosal Immunology,in press 2012) Reprinted with permission. 
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Table 5-1 Taxonomic annotations of operational taxonomic units (OTUs) with 
significant differences in abundance between MyD88Flox and MyD88∆IEC mice.  
Distinctive OTUs were identified by predictive analysis microarrays (see Figure 5-10c). 
(Frantz et al. Targeted deletion of MyD88 in intestinal epithelial cells results in 
compromised antibacterial immunity associated with the down-regulation of polymeric 
immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal Immunology,in 
press 2012) Reprinted with permission. 
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Table 5-2 Gene expression in colonic epithelial cells from MyD88Flox and MyD88∆IEC 
mice.  Colonic epithelial cells were isolated from 9 week-old mice . Relative levels of 36 
individual mRNA transcripts were analyzed by Nanostring nCounterTM hybridization and 
normalized to 4 housekeeping genes. B.D., below detection. (Frantz et al. Targeted 
deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial 
immunity associated with the down-regulation of polymeric immunoglobulin receptor, 
mucin-2 and antibacterial peptides. Mucosal Immunology,in press 2012) Reprinted with 
permission. 
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Table 5-3 DSS-induced changes in gene expression in colonic epithelial cells from 
MyD88Flox mice. Mice (8 weeks of age) were given 2% DSS or regular drinking water 
for 7 days prior to isolation of colonic epithelial cells. Relative levels of 36 individual 
mRNA transcripts were analyzed by Nanostring nCounterTM hybridization and 
normalized to 4 housekeeping genes. B.D., below detection. (Frantz et al. Targeted 
deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial 
immunity associated with the down-regulation of polymeric immunoglobulin receptor, 
mucin-2 and antibacterial peptides. Mucosal Immunology,in press 2012) Reprinted with 
permission. 
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Table 5-4 Differences in DSS-induced changes in gene expression in colonic 
epithelial cells from MyD88Flox and MyD88∆IEC mice.  Mice (8 weeks of age) were 
given 2% DSS in the drinking water for 7 days prior to isolation of colonic epithelial 
cells. Relative levels of 36 individual mRNA transcripts were analyzed by Nanostring 
nCounterTM hybridization and normalized to 4 housekeeping genes. B.D., below 
detection. (Frantz et al. Targeted deletion of MyD88 in intestinal epithelial cells results in 
compromised antibacterial immunity associated with the down-regulation of polymeric 
immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal Immunology,in 
press 2012) Reprinted with permission. 
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Figure 5-11.  Loss of MyD88 expression alters epithelial gene expression and 
compromises pIgR-mediated IgA transport. (a) Colonic epithelial cells were isolated 
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Figure 5-11 (continued) from 8 week-old MyD88IEC and MyD88Flox mice (n = 12). 
Levels of 36 individual mRNA transcripts were analyzed by Nanostring nCounterTM 
hybridization and plotted as mean fold difference (log2) between MyD88IEC and 
MyD88Flox mice vs. P-value (-log10). mRNA transcript levels for genes above the red 
dashed line were significantly different in MyD88IEC mice compared to MyD88Flox mice 
(p < 0.05). Genes to the left of the zero line were down-regulated, while genes to the right 
were up-regulated. (b) Immunofluorescence staining of colon tissues from 9 week-old 
MyD88Flox and MyD88IEC mice (pIgR = red, IgA = green, DAPI-stained nuclei = blue). 
(c) Feces were collected from 10 week old MyD88Flox and MyD88IEC mice and IgA 
levels were determined by ELISA. The asterisk indicate that the mean for MyD88IEC 
mice is significantly different from the mean for MyD88Flox mice (p<0.05). Data are 
expressed as mean ± SEM (n = 5). (d) Immunofluorescence staining of colon tissues 
from 9 week-old MyD88Flox and MyD88IEC mice (Muc2 = red, DAPI-stained nuclei = 
blue). (Frantz et al. Targeted deletion of MyD88 in intestinal epithelial cells results in 
compromised antibacterial immunity associated with the down-regulation of polymeric 
immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal Immunology,in 
press 2012) Reprinted with permission. 
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Figure 5-12. Loss of epithelial MyD88 expression does not affect goblet cell numbers 
in the colon. Images of formalin-fixed colon tissues from representative 10 week old 
mice, stained with hematoxylin and eosin, were captured with a 40X objective. (Frantz et 
al. Targeted deletion of MyD88 in intestinal epithelial cells results in compromised 
antibacterial immunity associated with the down-regulation of polymeric 
immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal Immunology,in 
press 2012) Reprinted with permission.  
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 Figure 5-13.  Loss of MyD88 expression in intestinal epithelial cells increases the 
severity of DSS-induced colitis. (a) Disease activity in MyD88Flox and MyD88IEC mice 
given regular drinking water or 2% DSS for 7 days. Data are expressed as mean ± SEM 
(n = 8). One asterisk indicates that the mean for DSS-treated mice is significantly greater 
than the corresponding mean for untreated mice, and two asterisks indicate that the mean 
for DSS-treated MyD88IEC mice is greater than the mean for DSS-treated MyD88Flox 
mice. (b) Colon histology from representative mice at day 7. Images of                    
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Figure 5-13 (continued) formalin-fixed colon tissues stained with hematoxylin and eosin 
were captured with a 20X objective. (c) Histological inflammatory scores for MyD88Flox 
and MyD88IEC mice on day 7 days. The asterisk indicate that the means for DSS-treated 
mice are significantly different from the means for untreated mice of the same genotype, 
and that the mean for MyD88IEC mice is significantly different from the mean for 
MyD88Flox mice (p<0.05). Data are expressed as mean ± SEM (n = 8).  (d) Principal 
component analysis was used to generate two-dimensional ordination plots that visualize 
complex relationships in expression of multiple genes in colonic EC of individual 
MyD88Flox and MyD88IEC mice, with or without DSS treatment. Normalized mRNA 
transcript levels for 19 genes were reduced to 2 PCs (see Figure 5-15 for details), which 
are plotted for individual mice. (e) Levels of 36 individual mRNA transcripts were 
measured by Nanostring nCounterTM hybridization. Data are plotted as mean fold 
difference (log2) between MyD88Flox mice with or without DSS treatment vs. P-value (-
log10) (upper panel), and mean fold difference (log2) between DSS-treated MyD88IEC 
and MyD88Flox mice vs. P-value (-log10) (lower panel). Individual dots represent the mean 
of treatment groups (n = 8). mRNA transcript levels for genes above the red dashed line 
were significantly different for each comparison (p < 0.05). Genes above the red dashed 
line were significantly different in DSS-treated mice compared to untreated mice 
(p<0.05). Genes to the left of the zero line were down-regulated, and genes to the right 
were up-regulated. (Frantz et al. Targeted deletion of MyD88 in intestinal epithelial cells 
results in compromised antibacterial immunity associated with the down-regulation of 
Figure 5-13 (continued) polymeric immunoglobulin receptor, mucin-2 and antibacterial 
peptides. Mucosal Immunology,in press 2012) Reprinted with permission. 
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Figure 5-14. Principal component analysis (PCA) of gene expression in colonic 
epithelial cells from MyD88∆IEC and MyD88Flox mice in the presence and absence of 
DSS treatment    (a) Nineteen genes from a total of 36 were selected for PCA, based on 
ranking of P values for the comparison of mRNA transcript levels in MyD88∆IEC and  
MyD88Flox mice, with and without DSS treatment (n = 31) (see Tables 5-2, 5-3 and 5-4). 
Data for mRNA transcript levels from individual mice were reduced to two principal 
components that accounted for 68.8% of the overall variance in gene expression (PC1 
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Figure 5-14 (continued) and PC2). Weighted coefficients are listed for each variable 
comprising PC1 and PC2. (b) PC1 and PC2 scores were calculated for each individual 
mouse as the sum of normalized expression levels for each gene multiplied by the 
corresponding coefficient for PC1 and PC2. Bar graphs indicate the mean + SEM for 
each treatment group (n = 7-9).  Asterisks indicate that the mean for DSS-treated mice is 
significantly different from the mean for untreated mice of the same genotype (p < 0.05). 
P-values for the comparisons between DSS-treated MyD88Flox and MyD88IEC mice are 
noted on the graph. (Frantz et al. Targeted deletion of MyD88 in intestinal epithelial cells 
results in compromised antibacterial immunity associated with the down-regulation of 
polymeric immunoglobulin receptor, mucin-2 and antibacterial peptides. Mucosal 
Immunology,in press 2012) Reprinted with permission. 
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Chapter Six – Discussion and Future Directions 
 
Maintenance of pIgR expression is required for intestinal homeostasis 
An important finding in this work is that the downregulation of pIgR expression 
that is observed in patients with IBD, is also a common feature in mouse models of acute 
and chronic experimental colitis. Notably, this downregulation in epithelial gene 
expression is correlated with disease severity. These results raise the question of whether 
dysregulation of pIgR expression is a cause or consequence of intestinal inflammation. It 
is possible that inflammation-induced damage to the intestinal epithelium may disrupt 
intracellular signaling pathways and alter protein trafficking, leading to the dysregulation 
of pIgR expression. For example, chronic inflammation has been shown to reduce the 
activity of critical chaperone proteins required for proper protein trafficking, resulting in 
loss of epithelial polarity201. Loss of epithelial polarity leads to dysregulation of pIgR 
expression and transport of IgA44. Thus, independent of the mechanism by which 
intestinal inflammation develops, pIgR expression is significantly impaired. We found 
that this defect is associated with dysregulated epithelial transcytosis of IgA, reduced 
levels of luminal SIgA, accumulation of IgA in the intestinal lamina propria, as well as 
increased levels of circulating IgA. Multiple studies suggest that reduced transport of 
SIgA exacerbates intestinal inflammation. pIgR deficient mice, which have significantly 
reduced SIgA in external secretions, were found to be more susceptible than wild-type 
mice to acute DSS-induced colitis58. Furthermore, pIgR deficient mice are more 
susceptible to a variety of bacterial infections202-204. Taken together, it can be concluded 
that maintaining high levels of pIgR expression is necessary to maintain intestinal 
homeostasis.     
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Not only does maintaining high levels of pIgR expression maintain sufficient 
transcytosis of SIgA, but it also provides sufficient levels of free SC in the intestinal 
lumen. The SC moiety of SIgA has also been shown to contribute to innate defense 
mechanisms, including prevention of bacterial adherence to the intestinal mucus layer 
and neutralization of potential pro-inflammatory factors 54,134. However, the work 
presented here suggests that expression of pIgR and transport of free SC has a role in 
protection against intestinal inflammation. Since Rag-\- mice do not produce IgA, any 
protective effects of T regulatory cells in this model do not involve maintaining IgA 
function. Interestingly, we found that in mice that received T effector and T regulatory 
cells, pIgR expression was restored to a level that was not significantly different than 
control mice.  Accordingly, weight loss, colon weight to length ratio and PC values for 
mice who received T effectors and T regulatory cells were no different than control mice.   
Thus, restoration of pIgR expression, independent of IgA, is associated with colitis 
prevention. It has recently been reported that anti-TNF therapy not only neutralizes TNF, 
but promotes the activation and expansion of T regulatory cells in CD patients 137. 
Accordingly, maintaining an environment that promotes pIgR expression in epithelial 
cells could be an additional mechanism by which T regulatory cells protect against T cell 
dependent intestinal inflammation and restore intestinal homeostasis.    
Overall these results suggest that therapeutic strategies aimed to maintain pIgR 
expression may be beneficial. Recently, probiotics, defined as live microorganisms that 
when administered in adequate amounts confer a health benefit on the host, are receiving 
increasing attention as potential treatment options for intestinal inflammation. However, 
the mechanisms by which probiotics achieve their beneficial effects remain unclear. 
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Interestingly, E. coli strain Nissle 1917 (EcN) is the best characterized probiotic strain of 
E.coli. EcN has been tested as a treatment for IBD in several clinical trials, and has been 
shown to be as effective as mesalazine in maintaining remission in ulcerative colitis 
patients166. In vitro experiments with cultured IEC have revealed several mechanisms by 
which EcN may act, including induction of tight junction proteins, maintenance of barrier 
function, inhibition of invasion by invasive bacteria, induction of antimicrobial β-
defensins and chemokine synthesis, and inhibition of TNF induced pro-inflammatory 
response205-207. Our lab has shown that EcN was unique among representative species of 
the four major phyla of human colonic bacteria in its ability to upregulate expression of 
pIgR in HT-29 cells62. Here we show that the induction of pIgR by EcN is mediated by 
the TLR4-MyD88 dependent activation of NF-κB. In particular, this response is 
primarily mediated by the classical RelA-dependent pathway, but the alternative RelB-
dependent pathway can compensate if necessary to maintain pIgR expression. Previous 
work has demonstrated that bacterial-dependent MyD88 signaling by IECs promotes B 
cell recruitment and IgA class-switching in the lamina propria4,19.  Accordingly, the 
induction and maintenance of high levels of pIgR expression, as well as enhanced IgA 
production, resulting in increased transport of SIgA and SC, may be an additional novel 
mechanism by which EcN achieves its probiotic effects. These results provide evidence 
for the continued investigation and the therapeutic use of EcN as a probiotic treatment. 
 
Epithelial MyD88 signaling in the colon 
A primary goal of this work was to understand the role of intestinal epithelial 
MyD88 signaling. The generation of mice with an epithelial-specific deletion of the 
146 
 
Myd88 gene is a relatively new model. Vaishnava et al.42 recently reported that 
MyD88∆IEC mice had reduced expression of the antimicrobial peptide RegIII-γ in the 
terminal ileum and increased bacterial colonization of small intestinal surfaces. These 
authors concluded that epithelial MyD88 regulation of RegIII-γ, which has specificity for 
Gram-positive bacteria, is a mechanism to restrict numbers of mucus-associated Gram-
positive bacteria in specific niches of the intestine. Consistent with these results, we show 
that RegIII-γ expression is reduced in the colon of MyD88∆IEC mice and extend these 
findings to show that the antimicrobial peptide Defa-rs1, which is constitutively 
expressed by IECs and upregulated in response to bacterial stimulation208, is also reduced 
in the colons of MyD88∆IEC mice. These defects are associated with reduced 
antimicrobial activity of colonic mucus, resulting in increased mucus-associated bacteria 
in the colon, similar to published results in the small intestine42. However, we show that 
MyD88∆IEC mice also have reduced expression of Muc-2 and pIgR (associated with 
reduced transcytosis of IgA), which was not observed by Vaishnava et al. in the small 
intestine of MyD88∆IEC mice. These discrepancies could be due to the structural and 
functional differences of these organs. It is logical to assume that the colon, which houses 
exponentially greater numbers of commensal bacteria than the small intestine, has 
evolved mechanisms to efficiently regulate expression of antimicrobial and innate 
immune genes to effectively deal with this huge bacterial load. Accordingly, our results 
support the idea that in the colon, antimicrobial peptides, with specificities for both 
Gram-positive and Gram-negative bacteria, as well as critical genes associated with 
epithelial barrier function and immunity (Muc-2 and pIgR) are regulated by commensal 
bacteria themselves. Thus, a feed-back system is established in which commensal 
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bacteria induce the expression, via epithelial MyD88 signaling, of epithelial genes 
required to maintain epithelial barrier function and homeostasis in the colon. In this 
situation, the function of colonic epithelial MyD88 signaling is unique compared to other 
cell types and locations.  
 
Novel role of epithelial MyD88 signaling in regulating pIgR expression  
Interestingly, pIgR was the most significantly downregulated gene in isolated 
epithelial cells from MyD88∆IEC mice. Furthermore, this downregulation of pIgR 
expression was associated with reduced transcytosis of SIgA and reduced levels of IgA in 
the feces of MyD88∆IEC mice. While it has been suggested that MyD88 signaling in 
epithelial cells regulates the expression of several genes necessary to maintain 
homeostasis6,78, this is the first study to demonstrate that epithelial MyD88 signaling is 
required to maintain sufficient pIgR expression and SIgA transcytosis in vivo. Our lab 
previously showed that pIgR expression and IgA transport was reduced in MyD88 
deficient mice160, but that study did not determine whether pIgR was regulated directly by 
MyD88 signaling in IECs or indirectly by immune cells in the intestinal lamina propria. 
While these new findings do not exclude the possibility that epithelial MyD88 signaling 
provides immune cells with signals that regulate the production of SIgA, these results do 
indicate that epithelial MyD88 signaling is necessary to regulate the expression of pIgR 
and transport of IgA. Accordingly, it would be interesting to examine pIgR expression 
and IgA transport in mice with myeloid-specific deletion of MyD88. Several studies had 
revealed an essential role for dendritic cell MyD88 signaling in luminal sampling and the 
induction of B cell differentiation in to IgA+ plasma cells6,209,210.  Using bone-marrow 
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chimeras it has been demonstrated that MyD88 signaling in myeloid cells mediates 
susceptibility to chronic intestinal inflammation6. It would be hypothesized that while 
pIgR expression may be slightly reduced in mice with MyD88-sufficient epithelial cells 
and MyD88-deficient myeloid cells, the production of IgA would be significantly altered; 
thus, dysregulated SIgA responses may also contribute to disease in this model.  
This work also reveals a novel role of epithelial NF-κB signaling, downstream of 
MyD88, in maintaining pIgR expression in response to commensal bacteria. While pro-
inflammatory responses to commensal bacteria are dependent on the classical RelA 
pathway, both the classical and alternative NF-κB pathways can induce pIgR expression. 
By utilizing signaling pathways that are distinct from those involved in regulating pro-
inflammatory responses, it is possible that IECs are able to upregulate pIgR expression in 
response to microbial and host stimuli while suppressing a potentially damaging pro-
inflammatory response. Taken together, these results suggest that the regulation of pIgR 
expression in IECs may be an important mechanism by which MyD88-dependent 
activation of NF-κB maintains intestinal homeostasis. Consistent with this idea, we found 
that loss of intestinal homeostasis associated with experimental colitis and human IBD is 
generally accompanied by reduced expression of epithelial RelA. Likewise, expression of 
RelA and pIgR were significant contributors to homeostatic PC1 in models of acute and 
chronic experimental colitis, as well as human CD.  
An important observation in this work is that loss of epithelial MyD88 signaling 
was associated with alterations in the composition of the gut microbiota. Interestingly, 
similar compositional changes have been observed in human IBD patients196. Altered 
host factors that are believed to impact commensal bacteria in IBD patients include 
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increased intestinal permeability, decreased production of antimicrobial peptides and 
aberrant SIgA responses196, all of which were observed in MyD88∆IEC mice. Specifically, 
IgA is known to have a role in shaping the composition of the microbiota by 
preferentially promoting the maintenance of beneficial and symbiotic bacterial 
communities19,211. In contrast, the composition of the microbiota has been shown to alter 
the production and transcytosis of IgA46,212. Taken together, our findings identify a novel 
role for epithelial MyD88 signaling in shaping the composition of the gut microbiota, at 
least in part by regulating pIgR expression and IgA transport. This idea highlights the 
complexity and importance of epithelial cells in integrating bacterial signals, as well as 
immune cell interactions, to promote intestinal homeostasis.     
 
MyD88 and TLR independent signaling pathways in the regulation of pIgR 
expression 
It should be noted that pIgR expression was significantly reduced in epithelial 
cells from MyD88∆IEC mice, not abolished. Inhibiting the binding of E.coli LPS to TLR4 
did appear to completely abolish the induction of pIgR, implying TLR4 signaling is 
required in response to commensal bacteria.  However, TLR4 utilizes both MyD88 and 
Trif to initiate target gene transcription.  Likewise, while shRNA mediated knockdown of 
MyD88 in HT-29 cells resulted in reduced expression of pIgR in unstimulated cells and 
reduced upregulation of pIgR expression in response to E.coli stimulation, it did not 
completely abolish this response. Furthermore, work presented here, as well as previous 
studies44,141, clearly demonstrates that TLR3 signaling, which is Trif-dependent and 
MyD88-independent, induces pIgR expression in vitro; however the specific contribution 
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of the Trif-dependent signaling pathway was not examined in these studies.  
Interestingly¸ this work, as well as previous work from the lab141, has shown that 
stimulation of TLR3 in HT-29 cells elicits a much stronger pro-inflammatory response 
than stimulation of TLR4, even though the induction of pIgR mRNA is similar.  Thus, it 
is probable that the Trif-dependent pathway, as well as additional signaling pathways, is 
responsible for maintaining the reduced level of pIgR expression observed in MyD88∆IEC 
mice, while the levels of most pro-inflammatory chemokines and cytokines remained 
unchanged. However, it has been demonstrated that Trif-\- bone marrow chimeras display 
no detectable differences in response to DSS treatment158, indicating TRIF signaling does 
not play a significant role in the setting of acute experimental colitis. Therefore, while 
TRIF-dependent signaling can induce pIgR expression, it probably plays a minor role 
during intestinal inflammation.    
Importantly, as demonstrated here, one common feature of the MyD88, TRIF and 
TNF signaling pathways in the induction of pIgR expression is the activation of NF-κB. 
While the MAPK signaling pathway contributed to the induction of the pro-inflammatory 
response, NF-κB was solely required for the induction of pIgR expression. Accordingly, 
it would be interesting to examine pIgR expression in NEMO∆IEC mice. Similar to 
MyD88∆IEC mice, reduced expression of antimicrobial peptides and increased bacterial 
translocation was observed in NEMO∆IEC mice34. However, unlike MyD88∆IEC mice, 
NEMO∆IEC mice develop severe spontaneous intestinal inflammation. Interestingly, 
crossing NEMO∆IEC mice with MyD88 deficient mice prevented the development of 
intestinal inflammation, demonstrating that bacterial-dependent TLR signaling is 
essential for the development of intestinal inflammation in this model34. We have made 
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the observation that downregulation of pIgR expression is correlated with disease 
severity in IBD patients and mouse models of colitis; therefore it would be hypothesized 
that pIgR expression and IgA transport would be greatly diminished in NEMO∆IEC mice, 
and that this defect could contribute to disease severity.  
Additional studies have demonstrated that host cytokines, including IL-4, IL-1, 
IFN-γ, TNF, and IL-17 can also induce pIgR expression in vitro44,160,213 in a TLR-
independent manner. IL-4, IFN- γ, and TNF have been shown to work synergistically to 
induce pIgR expression44, suggesting  cooperativity between host factors to maintain high 
pIgR expression.  It is likely that TLR-independent pathways are also affected in 
MyD88∆IEC mice. In particular, IL-1, whose receptor signals through MyD88 and is a 
MyD88 target gene, is a prominent pro-inflammatory cytokine released by macrophages 
that are recruited to the lamina propria in response to bacterial sampling and epithelial 
penetration214. IECs secrete IL-1 in an autocrine and paracrine manner in response to 
bacterial stimulation215. Here we observed that MyD88∆IEC mice were unable to 
upregulate epithelial IL-1 expression in response to DSS colitis. Accordingly, it is 
possible that the reduction in pIgR expression and IgA transport in MyD88∆IEC mice is, in 
part, due to an indirect effect of the loss of bacteria-induced MyD88 signaling, resulting 
in the inability to upregulate and respond to IL-1.   Consistent with this line of thinking, 
MyD88∆IEC mice were unable to upregulate epithelial TNF expression in response to DSS 
colitis, which was associated with increased disease severity. As we have shown here, 
TNF-dependent activation of NF-κB is a strong inducer of pIgR expression in IECs. 
Interestingly, it has previously been shown that chronic exposure of IECs to TNF in a cell 
culture model of chronic inflammation significantly increases pIgR mRNA stability143. 
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Therefore, the inability of MyD88∆IEC to upregulate epithelial TLR-induced TNF 
expression would also impair autocrine TNF signaling in IECs, further disabling the 
induction of pIgR expression and altering mRNA stability. Alternatively, MyD88∆IEC 
mice had increased histological inflammatory scores, including an increase in 
inflammatory immune cell infiltration into the lamina propria in response to DSS colitis. 
While gene expression was not analyzed in lamina propria immune cells, these 
inflammatory conditions are generally associated with increased production of 
inflammatory cytokines, including TNF, by macrophages and activated T cells. Thus, 
production of TNF, as well as other inflammatory stimuli, by MyD88-sufficient immune 
cells could signal in a paracrine fashion to induce pIgR expression in IECs, independent 
of epithelial MyD88 signaling, which could partially account for the pIgR expression in  
MyD88∆IEC mice. Nonetheless, the capacity of such diverse factors, as well as the 
utilization of several different signaling pathways, to induce pIgR expression suggests 
that maintaining high levels of pIgR and transport of SIgA and SC is of significant 
evolutionary importance for host fitness.  
 
Communication between all neighbors is required to prevent translocation of 
opportunistic bacteria.  
As previously mentioned, a significant finding in this work is that loss of 
epithelial-MyD88 signaling caused increased translocation of bacteria to the MLN. It has 
been proposed that low numbers of commensal bacteria continuously translocate the 
epithelial barrier in healthy immunocompetent hosts; however, these bacteria are 
generally killed en route or within the lymphoid organ, rarely ever establishing a 
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persistent presence216. This is not the case in MyD88∆IEC mice. Three primary 
mechanisms that promote the translocation of enteric bacteria from the intestine have 
been identified: Overgrowth of intestinal bacteria, deficiencies in host immune system, 
and increased epithelial permeability216. While an overgrowth of K. pneumoniae was not 
observed in MyD88 mice, multiple defects in innate immunity as well as increased 
epithelial permeability were observed. While these primary defects in epithelial defenses 
are central to the translocation of intestinal bacteria, cell-mediated immunity, including 
macrophages, neutrophils and T cells in the lamina propria are involved in reducing 
bacterial translocation216. Previous studies have demonstrated that the depletion of these 
cells types in the lamina propria promoted the translocation of E.coli into the MLN216,217.  
It has been suggested that epithelial TLR signaling is responsible for releasing soluble 
factors that regulate the development of secondary lymphoid structures, recruitment of 
immune cells to the lamina propria, as well as antigen sampling by DCs1,6,218,219.  It is 
likely that a loss of MyD88 signaling in epithelial cells affects the development, 
recruitment and function of MyD88-sufficient immune cells. This idea is supported by 
the results from Ismail et al.192who found that expression of RegIII-γ in small intestinal 
γδ intraepithelial lymphocytes (IELs) was dependent on epithelial-specific MyD88 
signaling, but was not dependent on expression of MyD88 within the IELs themselves. 
Thus, not only does loss of epithelial MyD88 signaling cause defects in epithelial 
defenses, it may also lead to lamina propria immune cell dysfunction, further promoting 
bacterial translocation and susceptibility to intestinal inflammation.  
Importantly, a dramatic increase in the translocation of Klebsiella pneumoniae 
was observed in MLN from MyD88∆IEC mice. This bacterial species is the most clinically 
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important member of the Klebsiella genus of the family Enterobacteriaceae, due to its 
role in nosocomial lung and intestinal infections in pediatric patients220,221.  It has 
recently been shown that oral infection with K. pneumoniae exacerbated intestinal 
inflammation in DSS colitis222.  While the technique used to identify bacteria in the MLN 
only allows the identification of live culturable bacteria, the fact that translocation of K 
pneumoniae was observed in >95% of MyD88∆IEC mice and very rarely in MyD88-
sufficient mice indicates that epithelial MyD88 signaling may have general and specific 
roles in antibacterial immunity. K. pneumoniae is an encapsulated bacterium.  This 
capsule is considered a virulence factor because it prevents desiccation and phagocytosis 
by host immune phagocytes and thus enhances the ability of the bacteria to cause disease. 
Accordingly, it is possible that loss of epithelial MyD88 signaling specifically increases 
susceptibility to resilient opportunistic bacteria. While facultative, encapsulated anaerobic 
bacteria in the Enterobacteriacceae family are considered to translocate at high 
efficiency, both E. coli and Proteus mirabilis are thought to be the most efficient at 
translocation216,223.  However, increased translocation of E. coli, and/or an overgrowth of 
either E. coli or Proteus mirabilis, was not observed in MyD88∆IEC mice. Taken together, 
these results support the idea that epithelial MyD88 signaling is required to defend 
against K. pneumoniae adherence and penetration of the epithelial layer, as well as 
indirectly required to efficiently kill bacteria that have penetrated the epithelial barrier. 
Bacterial translocation is considered an important early step in the pathogenesis of 
opportunistic infections216. Although there have been recent reports of MyD88-dependent 
immune responses to lung infection with K. pneumoniae195,224, the role of MyD88 
signaling in enteric infections with this opportunistic pathogen has not been studied. 
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While we detected significant numbers of K. pneumoniae in the MLNs of MyD88∆IEC 
mice, we were unable to detect these bacteria in the spleen, suggesting that the 
antibacterial activity of MyD88-sufficient immune cells was sufficient to prevent 
systemic infection. Therefore while this suboptimal immunity of MyD88∆IEC mice may 
be sufficient to control the numbers of K. pneumoniae normally found in the commensal 
gut microbiota, it may be insufficient to control larger numbers of K. pneumoniae. 
Accordingly, it would be hypothesized that MyD88∆IEC mice would be more susceptible 
than MyD88Flox mice to enteric infection with K. pneumoniae. The results could offer the 
potential to increase our understanding of the pathogenesis of opportunistic enteric 
infections in immunocompromised individuals.  
 
Role of MyD88-sufficient lamina propria immune cells in the regulation of intestinal 
homeostasis. 
One important aspect that was not addressed in these studies is the effect of loss 
of epithelial MyD88 signaling on MyD88-sufficient immune cells of the lamina propria. 
As previously mentioned in this chapter, it is possibly that loss of epithelial MyD88 
signaling could have indirect effects on the production of SIgA. However, expression of 
B cell activating factor, BAFF (Tnsf13b), as well as the lymphocyte growth factor thymic 
stromal lymphopoietin (TSLP), in isolated ECs from MyD88Flox and MyD88∆IEC mice 
were below the detectable limit. It would be worthwhile to compare the expression of 
other epithelial-derived factors that influence B cell differentiation, such as a proliferating 
inducing ligand (APRIL), in MyD88Flox and MyD88∆IEC mice. APRIL has been shown to 
be released by IECs in response to TLR signaling and can directly induce B cell 
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differentiation225. Furthermore, while immunofluorescence analysis of IgA expression in 
colonic sections did not reveal differences in the presence of IgA+ plasma cells in the 
lamina propria, the presence of additional immune cell types was not investigated. It 
would be valuable to analyze the cellular composition of immune cells isolated from the 
lamina propria of MyD88Flox and MyD88∆IEC mice. As previously discussed, while the 
translocation of bacteria, in particular K. pneumoniae, observed in MyD88∆IEC mice is a 
result of defective epithelial barrier function, the ability of these bacteria to survive transit 
to the MLN suggests an impairment of lamina propria immune cells to efficiently 
contain these bacteria that have penetrated the epithelium. For example, impairment in 
the recruitment of DCs and T cell into the lamina propria could also indirectly effect the 
production of SIgA.  Analyzing the cellular composition of the lamina propria immune 
cells may provide insight into the cell-types responsible for these antibacterial and 
immune defects.  
It would also be important to analyze pro-inflammatory gene expression in 
isolated lamina propria immune cells from MyD88Flox and MyD88∆IEC mice.  By using a 
model in which MyD88 expression is restricted to myeloid cells, Malvin et al. have 
recently shown that myeloid cells, macrophages in particular, in untreated mice are in an 
activated state displaying enhanced NF-κB activity226. These authors conclude that 
MyD88 signaling in non-myeloid cells can inhibit myeloid cell activation. Considering 
the increase in bacterial penetration of the intestinal epithelium that was observed in 
MyD88∆IEC mice, it would be hypothesized that the lamina propria of MyD88∆IEC would 
also contain hyperactivated-immune cells. Here we have shown that THP-1 monocytes 
are hyper-responsive to TLR stimulation, as compared to HT-29 epithelial cells. 
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Furthermore, it is possible that while this hyper-activated state may offer some level of 
immune protection against the normal microbiota in MyD88∆IEC mice, it may be 
damaging in response to the high bacterial stimulation that occurs with DSS treatment. 
Accordingly, Asquith et al. demonstrated that MyD88 signaling in hematopoietic cells 
were responsible for the pro-inflammatory responses that increased colitis severity scores 
in these bone marrow chimeric mice159. It is possible that these effects could contribute to 
the enhanced susceptibility of MyD88∆IEC mice to DSS.  
 
Bacterial-dependent signaling by IECs regulates intestinal homeostasis and 
inflammation 
Taken together, the results presented here suggest a model in which maintenance 
of intestinal homeostasis requires active communication among the microbiota, epithelial 
cells and immune cells. However, while communication must occur, physical and 
immunological barriers must be maintained.  Protection against bacterial invasion and the 
development of inflammation in the intestine is dependent on the resident microbiota, the 
mucus layer containing SIgA and antimicrobial peptides, and the monolayer of IECs that 
provide a physical and innate immune barrier.  Here we demonstrate that MyD88 
signaling in IECs is a main regulator of these processes in the colon (Figure 6-1A). 
Epithelial MyD88 signaling regulates the expression of Muc-2, the main structural 
component of colonic mucus, as well as the expression of antimicrobial peptides. 
Importantly, MyD88 signaling in epithelial cells regulates the expression of pIgR and the 
transport of SIgA. In response to E. coli, the regulation of pIgR induction is dependent on 
the TLR4-activation of NF-κB.  However, when dysregulation of these defenses occur, 
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bacterial translocation and intestinal inflammation can result (Figure 6-1B). Accordingly, 
the loss of epithelial MyD88 signaling leads to reduced mucin secretion, reduced mucus-
associated antimicrobial activity, reduced transcytosis of SIgA and increased epithelial 
permeability. These impairments in antibacterial and innate immunity result in alterations 
in the composition of the resident microbiota, increased numbers of mucus-associated 
bacteria and increased bacterial translocation to the mesenteric lymph nodes. The 
inability to maintain homeostasis with the intestinal microbiota increases the host’s 
susceptibility to intestinal inflammation and systemic infection. Notably, sustained 
reduction of pIgR expression and altered transport of SIgA are characteristic of intestinal 
inflammation and further exacerbates disease. Taken together, these results highlight the 
critical role of intestinal epithelial cells in maintaining intestinal homeostasis and suggest 
that changes in IEC gene expression and function may be central to understanding the 
underlying mechanisms of intestinal inflammation and disease. As a result, a 
multifactorial approach to examine epithelial gene expression may be the most 
informative for the diagnosis of intestinal disease and for evaluating potential therapeutic 
options. These results provide insight into the importance of the complex relationships 
between bacteria and IECs, as well as IECs and immune cells, and offer evidence for the 
continued investigations into potential therapeutic strategies. Thus in the intestine, good 
epithelial fences do make good neighbors. 
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Figure 6-1 Bacterial-dependent signaling by IEC is required to maintain intestinal 
homeostasis. (A) Under homeostatic conditions, colonic epithelial cells maintain a 
physical and immunological barrier. Bacterial-dependent MyD88 signaling regulates 
muc-2 production in goblet cells; regulates expression of antimicrobial peptides; 
regulates the expression of pIgR and the transport of SIgA via activation of NF-κB; and 
maintains an impermeable epithelial barrier. (B) Loss of colonic epithelial MyD88 
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Figure 6-1 (continued) expression results in dysregulation of Muc-2, AMPs, and pIgR 
expression as well as impairs SIgA transport and increases epithelial permeability. These 
defects cause increased bacterial adherence and translocation, increasing the host’s 
susceptibility to intestinal inflammation. (Adapted with permission from Hooper et al. 
Nat. Rev. Immunol. 10(3):159-69 2010) 
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